Research

Packages

Life of the unit

Next seminars

25 mai 2018 à préciser à préciser

22 juin 2018 à préciser Journée Scientifique conjointe de l'unité SPHERE et de l'unité ECEVE

Last publications

Updated

Les publications de l'equipe

2018

Articles dans une revue internationale

• 1. Nadal M, Levy M, Bakhsh A, Joly A, Maruani A, Vaillant L, Erra B, Samimi M (2018) Salivary scintigraphy for Sjögren's syndrome in patients with xerostomia: A retrospective study. Oral Dis, 24(4): 552-60.


• 2. Moawad S, Mahé E, Aubert- Wastiaux H, Phan A, Maruani A, Chiaverini C, Bodemer C, Mazereeuw-Hautier J, Lasek-Duriez A, Droitcourt C, Barbarot S, Beauchet A, Bursztejn A, Groupe de Recherche de la Société Française de Dermatologie Pédiatrique (2018) Topical Corticosteroid Concerns Among Parents of Children with Psoriasis versus Atopic Dermatitis: A French Multicenter Cross-Sectional Study. Am J Clin Dermatol, 19(2): 261-5.


• 3. Diguisto C, Winer N, Descriaud C, Tavernier E, Weymuller V, Giraudeau B, Perrotin F (2018) Amnioinfusion for women with a singleton breech presentation and a previous failed external cephalic version: a randomized controlled trial. J Matern Fetal Neonatal Med, 31(8): 993-9.


• 4. Contentin L, Frasca D, Tavernier E, Feuillet F, Foucher Y, Giraudeau B (2018) Ventilator-Free Day Outcomes Can Be Misleading. Crit Care Med, 46(3): 425-429.


• 5. Beslon V, Moreau P, Maruani A, Maisonneuve H, Giraudeau B, Fournier J (2018) Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review. J Gen Intern Med, 33(3): 358-66.


• 6. Samimi M, Durieux-Verde M, Caille A, Mazereeuw-Hautier J, Boccara O, Martin L, Chiaverini C, Eschard C, Beneton N, Vabres P, Balguerie X, Plantin P, Bessis D, Barbarot S, Dadban A, Droitcourt C, Leducq S, Lorette G, Morel B, Maruani A, Groupe de Recherche de la Société Française de Dermatologie Pédiatrique (2018) Clinical and haemodynamic risk factors associated with discrepancies in lower limb length with capillary malformations: data from the national paediatric French cohort CONAPE. Br J Dermatol, 178(2): 520-6.


• 7. Maruani A, Durieux-Verde M, Mazereeuw-Hautier J, Boccara O, Martin L, Chiaverini C, Eschard C, Beneton N, Vabres P, Balguerie X, Plantin P, Bessis D, Barbarot S, Dadban A, Droitcourt C, Berthelot A, Lorette G, Leducq S, Samimi M, Andres C, Caille A, Vourc'h P, Groupe de Recherche de la Société Française de Dermatologie (2018) Search for RASA1 Variants in Capillary Malformations of the Legs in 113 Children: Results from the French National Paediatric Cohort CONAPE. Acta Derm Venereol , 98(2): 251-5.


• 8. Cornillier H, Giraudeau B, Munck S, Hacard F, Jonville-Bera AP, d'Acremont G, Pham B, Maruani A (2018) Chronic spontaneous urticaria in children - a systematic review on interventions and comorbidities. Pediatr Allergy Immunol: Epub ahead of print.


• 9. Finon A, Zaragoza J, Maillard H, Beneton N, Bens G, Samimi M, Caille A, Machet L (2018) A high neutrophil to lymphocyte ratio prior to BRAF inhibitor treatment is a predictor of poor progression-free survival in patients with metastatic melanoma. Eur J Dermatol, 28(1): 38-43.


• 10. Bailly E, Von Tokarski F, Beau-Salinas F, Picon L, Miquelestorena-Standley E, Rousseau G, Jonville-Bera AP, Halimi JM (2018) Interstitial Nephritis Secondary to Vedolizumab Treatment in Crohn Disease and Safe Rechallenge Using Steroids: A Case Report. Am J Kidney Dis, 71(1): 142-5.


• 11. Revol B, Jullian-Desayes I, Bailly S, Mallaret M, Tamisier R, Agier MS, Lador F, Joyeux-Faure M, Pépin J (2018) Baclofen and sleep apnoea syndrome: analysis of VigiBase, the WHO pharmacovigilance database. Eur Respir J, 51(1): pii: 1701855. doi: 10.1183/13993003.01855-2017.


• 12. Querard AH, Le Borgne F, Dion A, Giral M, Mourad G, Garrigue V, Rostaing L, Kamar N, Loupy A, Legendre C, Morelon E, Buron F, Foucher Y, Dantan E (2018) Propensity score-based comparison of the graft failure risk between kidney transplant recipients of standard and expanded criteria donor grafts: towards increasing the pool of marginal donors.. American Journal of Transplantation: .

2017

Articles dans une revue internationale

• 1. Asehnoune K, Lasocki S, Seguin P, Geeraerts T, Perrigault P, Dahyot-Fizelier C, Paugam-Burtz C, Cook F, Demeure Dit Latte D, Cinotti R, Mahé PJ, Fortuit C, Pirracchio R, Feuillet F, Sébille V, Roquilly A (2017) Association between continuous hyperosmolar therapy and survival in patients with traumatic brain injury - a multicentre prospective cohort study and systematic review.. Critical Care, 21(1): 328.


• 2. Robert R, Le Gouge A, Kentish-Barnes N, Cottereau A, Giraudeau B, Adda M, Annane D, Audibert J, Barbier F, Bardou P, Bourcier S, Bourenne J, Boyer A, Brenas F, Das V, Desachy A, Devaquet J, Feissel M, Ganster F, Garrouste-Orgeas M, Grillet G, Guisset O, Hamidfar-Roy F, Hyacinthe AC, et al (2017) Terminal weaning or immediate extubation for withdrawing mechanical ventilation in critically ill patients (the ARREVE observational study). Intensive Care Med, 43(12): 1793-1807.


• 3. Barais M, Laporte C, Schuers M, Saint-Lary O, Frappé P, Dibao-Dina C, Darmaun D, Bouchez T, Gelly J (2017) Cross-sectional multicentre study on the cohort of all the French junior lecturers in general practice. Eur J Gen Pract, 24(1): 99-105.


• 4. Dany A, Rapin A, Lavallart B, Saoüt V, Reveillère C, Bassez G, Tiffreau V, Péréon Y, Sacconi S, Eymard B, Dramé M, Jolly D, Novella JL, Hardouin JB, Boyer F (2017) The quality of life in genetic neuromuscular disease questionnaire: Rasch validation of the French version.. Muscle Nerve, 56(6): 1085-1091.


• 5. Gillaizeau F, Senage T, Le Borgne F, Le Tourneau T, Roussel J, Leffondrè K, Porcher R, Giraudeau B, Dantan E, Foucher Y (2017) Inverse probability weighting to control confounding in an illness-death model for interval-censored data.. Stat Med: Epub ahead of print.


• 6. Bouquet E, Jourdain M, Machet M, Beau-Salinas F, Jonville-Bera AP (2017) Dasatinib-associated follicular lymphoid hyperplasia: First pediatric case report and literature review. Pediatr Blood Cancer, 64(11): doi: 10.1002/pbc.26597. Epub 2017 Apr 25.


• 7. Salmon M, Blanchin M, Rotonda C, Guillemin F, Sébille V (2017) Identifying patterns of adaptation in breast cancer patients with cancer-related fatigue using response shift analyses at subgroup level. Cancer Medicine, 6(11): 2562-2575.


• 8. Perrot B, Anthoine E, Hardouin JB (2017) Validscale : A Stata module to validate measurement scales. Stata Journal: under press.


• 9. Fournier MC, Dantan E, Blanche P (2017) An R2-curve for evaluating the accuracy of dynamic predictions. : .


• 10. Denis F, Bizien P, Tubert-Jeanin S, Hamad M, Trojak B, Rude N, Hardouin JB (2017) A Rasch analysis between schizophrenic patients and the general population. Behavioral neuroscience, 8: 139-146.


• 11. Le Cleach L, Lebrun-Vignes B, Bachelot A, Beer F, Berger P, Brugère S, Chastaing M, Do-Pham G, Ferry T, Gand-Gavanou J, Guigues B, Join-Lambert O, Henry P, Khallouf R, Lavie E, Maruani A, Romain O, Sassolas B, Tran V, Guillot B, French Acne Guidelines Working Group and Centre of Evidence of Dermatology (2017) Guidelines for the management of acne: recommendations from a French multidisciplinary group. , 177(4): 908-13.


• 12. Nicolas C, Le Gouge A, d'Alteroche L, Ayoub J, Georgescu M, Vidal V, Castaing D, Cercueil J, Chevallier P, Roumy J, Trillaud H, Boyer L, Le Pennec V, Perret C, Giraudeau B, Perarnau JM, Stic-Tips Group (2017) Evaluation of Doppler-ultrasonography in the diagnosis of transjugular intrahepatic portosystemic shunt dysfunction: A prospective study. World J Hepatol, 9(27): 1125-32.


• 13. Rousselet M, Feuillet F, Gérardin M, Jolliet P, Hardouin JB, Victorri-Vigneau C (2017) The French addictovigilance network clinical assessment: Z-drugs, true false twins. Expert Opinion on Drug safety, 16(9): 1063-1069.


• 14. Roquilly A, Lasocki S, Moyer J, Huet O, Perrigault P, Dahyot-Fizelier C, Seguin P, Sharshar T, Geeraerts T, Remerand F, Feuillet F, Asehnoune K (2017) COBI (COntinuous hyperosmolar therapy for traumatic Brain-Injured patients) trial protocol: a multicentre randomised open-label trial with blinded adjudication of primary outcome. BMJ Open, 7(9): .


• 15. Le Moigne M, Bulteau S, Grall-Bronnec M, Gerardin M, Fournier J, Jonville-Bera AP, Jolliet P, Dreno B, Victorri-Vigneau C (2017) Psychiatric disorders, acne and systemic retinoids: comparison of risks. Expert Opin Drug Saf, 16(9): 989-95.


• 16. Diguisto C, Le Gouge A, Giraudeau B, Perrotin F (2017) Mechanical cervicAl ripeninG for women with PrOlongedPregnancies (MAGPOP): protocol for a randomised controlled trial of a silicone double balloon catheter versus the Propess system for the slow release of dinoprostone for cervical ripening of prolonged p. BMJ Open, 7(9): e016069.


• 17. Rouillon S, Deshayes-Morgand C, Rabouan S, Enjalbert L, Hardouin JB, Group DisProSE , Migeot V, Albouy-Llaty M (2017) Endocrine Disruptors and Pregnancy: Knowledge, Attitudes and Prevention Behaviors of French Women. Int. J. Environ. Res. Public Health, 14: 1021.


• 18. Grall-Bronnec M, Victorri-Vigneau C, Donnio Y, Leboucher J, Rousselet M, Thiabaud E, Zreika N, Derkinderen P, Challet G (2017) Dopamine Agonists and Impulse Control Disorders: A Complex Association. Drug Safety: under press.


• 19. Taljaard M, Hemming K, Shah L, Giraudeau B, Grimshaw J, Weijer C (2017) Inadequacy of ethical conduct and reporting of stepped wedge cluster randomized trials: Results from a systematic review. Clin Trials, 14(4): 333-41.


• 20. Asehnoune K, Seguin P, Lasocki S, Roquilly A, Delater A, Gros A, Denou F, Mahé PJ, Nesseler N, Demeure Dit Latte D, Launey Y, Lakhal K, Rozec B, Mallédant Y, Sébille V, Jaber S, Le Thuaut A, Feuillet F, Cinotti R (2017) Extubation Success Prediction in a Multicentric Cohort of Patients with Severe Brain Injury. Anesthesiology, 127(2): 338-346.


• 21. Mouneyrac A, Lemercier C, Le Floch V, Challet G, Moreau A, Jacques C, Giroux I (2017) Cognitive Characteristics of Strategic and Non-strategic Gamblers. Journal of Gambling Studies: under press.


• 22. Desmée S, Mentré F, Veyrat-Follet C, Sebastien B, Guedj J (2017) Nonlinear joint models for individual dynamic prediction of risk of death using Hamiltonian Monte Carlo: application to metastatic prostate cancer. BMC Med Res Methodol, 17(1): 105.


• 23. Diguisto C, Piver E, Le Gouge A, Eboue F, Vaillant C, Maréchaud M, Goua V, Giraudeau B, Perrotin F (2017) First trimester uterine artery Doppler, sFlt-1 and PlGF to predict preeclampsia in a high-risk population. J Matern Fetal Neonatal Med, 30(13): 1514-9.


• 24. Rousselet M, Duretete O, Hardouin JB, Grall-Bronnec M (2017) Cult membership: What factors contribute to joining or leaving?. Psychiatry Research, 257: 27-33.


• 25. Asehnoune K, Mrozek S, Perrigault P, Seguin P, Dahyot-Fizelier C, Lasocki S, Pujol A, Martin M, Chabanne R, Muller L, Hanouz J, Hammad E, Rozec B, Kerforne T, Ichai C, Cinotti R, Geeraerts T, Elaroussi D, Pelosi P, Jaber S, Dalichampt M, Feuillet F, Sebille V, Roquilly A (2017) A multi-faceted strategy to reduce ventilation-associated mortality in brain-injured patients. The BI-VILI project: a nationwide quality improvement project. Intensive Care Med, 43(7): 957-970.


• 26. Brun J, Chiaverini C, Devos G, Leclerc-Mercier S, Mazereeuw J, Bourrat E, Maruani A, Mallet S, Abascq C, Phan A, Vabres P, Martin L, Bodemer C, Lagrange S, Lacour J, Resarch Group of the French Society of Pediatric Dermatology (2017) Pain and quality of life evaluation in patients with localized epidermolysis bullosa simplex. Orphanet J Rare Dis, 12(1): 119.


• 27. Lepère V, Vanier A, Loncar Y, Lemoine L, Vaillant J, Monsel A, Savier E, Coriat P, Eyraud D (2017) Risk factors for pulmonary complications after hepatic resection. Role of intraoperative hemodynamic instability and hepatic ischemia. , 17(1): 84.


• 28. Bruneau M, Colombel A, Mirallie S, Fréour T, Hardouin JB, Barriere P, Grall-Bronnec M (2017) Desire for a child and eating disorders in women seeking infertility treatment. Plos ONE, 12(6): e0178848.


• 29. Molto A, Tézenas du Montcel S, Wendling D, Dougados M, Vanier A, Gossec L (2017) Disease activity trajectories in early axial spondyloarthritis: results from the DESIR cohort. Annals of Rheumatic Diseases, 76(6): 1036-1041.


• 30. Raffin D, Zaragoza J, Georgescou G, Mourtada Y, Maruani A, Ossant F, Patat F, Vaillant L, Machet L (2017) High-frequency ultrasound imaging for cutaneous neurofibroma in patients with neurofibromatosis type I. Eur J Dermatol, 27(3): 260-5.


• 31. Von Theobald L, Rousselet M, Cholet J, Debar H, Boels D, Victorri-Vigneau C, Grall-Bronnec M (2017) Inpatient Gamma-Hydroxybutyrate detoxification: a case report describing day-to-day therapeutic management. Journal of addiction medicine, 11(3): 231-4.


• 32. Perrot B, Hardouin JB, Costes JM, Caillon J, Grall-Bronnec M, Challet G (2017) Study protocol for a transversal study to develop a screening model for excessive gambling behaviors on a representative sample of users of French authorized gambling websites. BMJ Open, 7(5): e014600.


• 33. Terrier LM, Bauchet L, Rigau V, Amelot A, Zouaoui S, Filipiak I, Caille A, Almairac F, Aubriot-Lorton M, Bergemer-Foucquet A, Bord E, Cornu P, Czorny A, Dam Hieu P, Debono B, Delisle M, Emery E, Farah W, Gauchotte G, Godfraind C, et al. (2017) Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database. Neuo Oncol, 19(5): 678-88.


• 34. Bernardeschi D, Pyatigorskaya N, Vanier A, Bielle F, Smail M, Sterkers O, Kalamarides M (2017) Role of electrophysiology to guide near-total resection for facial nerve function perservation in large vestibula schwanoma surgery. Journal of Neurosurgery: [Epub, ahead of print].


• 35. Desoubeaux G, Franck-Martel C, Caille A, Drillaud N, Lestrade Carluer de Kyvon M, Bailly E, Chandenier J (2017) Use of calcofluor-blue brightener for the diagnosis of Pneumocystis jirovecii pneumonia in bronchial-alveolar lavage fluids: A single-center prospective study. Med Mycol, 55(3): 295-301.


• 36. Pasquier L, Kirouani M, Fanget F, Nomine C, Caillard C, Arnault V, Finel JB, Christou N, Mathonnet M, Trésallet C, Hamy A, de Calan L, Brunaud L, Menegaux F, Lifante JC, Hardouin JB, Drui D, Mirallié E, Blanchard C (2017) Assessment of the Aldosteronona resolution score as a predictive resolution score of hypertension after adrenalectomy for aldosteronoma in French patients. Langenbeck's Archives of Surgery, 402(2): 309-314.


• 37. Desmée S, Mentré F, Veyrat-Follet C, Sebastien B, Guedj J (2017) Using the SAEM algorithm for mechanistic joint models characterizing the relationship between nonlinear PSA kinetics and survival in prostate cancer patients. Biometrics, 73(1): 305-12.


• 38. Vanier A, Mariette X, Tubach F, Fautrel B (2017) Cost-effectiveness of TNF-blockers injections spacing for patients with established rheumatoid arthritis in remission: an economic evaluation from the Spacing of TNF-blockers injections in Rheumatoid ArhritiS trial. Value in Health, 20(4): 577-585.


• 39. Torres R, N'guyen Y, Vanier A, Smail M, Ferray E, Sterkers O, Kalamarides M, Bernardeschi D (2017) Multivariate Analysis of Factors Influencing Facial Nerve Outcome following Microsurgical Resection of Vestibular Schwannoma. Otolaryngology Head and Neck Surgery, 156(3): 525-533.


• 40. Gorsane MA, Reynaud M, Vénisse JL, Legauffre C, Valleur M, Magalon D, Fatseas M, Chéreau-Boudet I, Guilleux A, JEU Group , Challet G, Grall-Bronnec M (2017) Gambling disorder-related illegal acts: Regression model of associated factors. J Behav Addict, 6(1): 64-73.


• 41. Baayen C, Feuillet F, Clermidi P, Crétolle C, Sarnacki S, Podevin G, Hardouin JB (2017) Validation of the French versions of the Hirschsprung’s disease and Anorectal malformations Quality of Life (HAQL) questionnaires for adolescents and adults. Health and Quality of Life Outcomes, 15: 24.


• 42. Lamirault G, de Bock E, Sébille V, Delasalle B, Roncalli J, Susen S, Piot C, Trochu JN, Teiger E, Neuder Y, Le Tourneau T, Manrique A, Hardouin JB, Lemarchand P (2017) Sustained quality of life improvement after intracoronary injection of autologous bone marrow cells in the setting of acute myocardial infarction: results from the BONAMI trial. Quality of Life Research, 26(1): 121-125.


• 43. Gras-Le Guen C, Caille A, Launay E, Boscher C, Godon N, Savagner C, Descombes E, Gremmo-Feger G, Pladys P, Saillant D, Legrand A, Caillon J, Barbarot S, Rozé J, Giraudeau B (2017) Dry Care Versus Antiseptics for Umbilical Cord Care: A Cluster Randomized Trial. Pediatrics, 139(1): pii: e20161857.


• 44. Guillou-Landreat M, Victorri-Vigneau C, Gérardin M (2017) Gambling disorder: a side effect of an off-label prescription of baclofen—literature review. BMJ Case Reports: .


• 45. Grall-Bronnec M, Sauvaget A, Boutin C, Bulteau S, Jiménez-Murcia S, Fernández-Aranda F, Challet G, Caillon J (2017) Excessive trading, a gambling disorder in its own right? A case study on a French disordered gamblers cohort. Addictive Behaviors, 64: 340–8.


• 46. Le Borgne F, Combescure C, Gillaizeau F, Giral M, Chapal M, Giraudeau B, Foucher Y (2017) Standardized and weighted time-dependent ROC curves to evaluate the intrinsic prognostic capacities of a marker by taking into account confounding factors. Statistical Methods in Medical Research: .


• 47. Tessier P, Blanchin M, Sébille V (2017) Does the relationship between health-related quality of life and subjective well-being change over time? An exploratory study among breast cancer patients. Social Science & Medicine, 174: 96-103.


• 48. Bourdon M, Roussiau N, Bonnaud-Antignac A (2017) Spiritual transformations after the diagnosis of melanoma affect life satisfaction via indirect pathways. . Journal for the Study of Spirituality: in press.


• 49. Bonnaud-Antignac A, Bourdon M, Dréno B, Quéreux G (2017) Coping strategies at the time of diagnosis and quality of life two years later: A study in primary cutaneous melanoma patients. Cancer Nursing, 40(1): E45-E53.

Chapitres d'ouvrage

• 1. Vanier A, Falissard B, Sébille V, Hardouin JB (2017) The complexity of interpreting changes observed over time in Health-Related Quality of Life: a short overview of 15 years of research on response shift theory. In Guillemin F, Leplège A, Briançon S, Spitz E, Coste J. Perceived health and adaptation in chronic disease. Stakes and future challenge (Taylor and Francis): 202-230.

Articles dans une revue nationale

• 1. Simon C, Lengellé C, Agier MS, Beau-Salinas F, Vrignaud L, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(11): 1150-7.


• 2. Alami Z, Agier MS, Ahid S, Vial T, Dautriche A, Lagarce L, Toutain A, Cherrah Y, Jonville-Bera AP (2017) Pregnancy outcome following in utero exposure to azathioprine: A French comparative observational study. Therapie: pii: S0040-5957(17)30152-X. doi: 10.1016/j.therap.2017.06.006. [Epub ahead of print].


• 3. Beau-Salinas F, Bouquet E, Vrignaud L, Simon C, Agier MS, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(9): 906-7.


• 4. Vrignaud L, Simon C, Agier MS, Bejan-Angoulvant T, Bouquet E, Beau-Salinas F, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(8): 783-7.


• 5. Beau-Salinas F, Bouquet E, Vrignaud L, Simon C, Agier MS, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(5): 501-6.


• 6. Agier MS, Marchand S, Paret N, Gautier S, Jonville-Bera AP (2017) [Post-licensure safety surveillance for Prevenar 13® in France]. Arch Pediatr, 24(5): 439-44.


• 7. Maruani A, Giraudeau B, Abdo I, Raphaël P (2017) [Risk of ischaemic heart disease and cardiovascular mortality in patients with hidradenitis suppurativa]. Ann Dermatol Venereol, 144(3): 230-2.


• 8. Weber E, Moulis G, Mahévas M, Guy C, Lioger B, Durieu I, Hunault M, Ramanantsoa M, Royer B, Default A, Perault-Pochat M, Moachon L, Bernard N, Bardy G, Jonville-Bera AP, Geniaux H, Godeau B, Cathébras P (2017) [Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study]. Rev Med Interne, 38(3): 167-75.


• 9. Guillou-Landreat M, Le Reste JY, Théréné-Mouden C, Caillon J, Cholet J, Grall-Bronnec M (2017) Les jeux de hasard et d’argent chez les sujets âgés. Soins gérontologie, 22(123): 35-7.


• 10. Agier MS, Beau-Salinas F, Bejan-Angoulvant T, Lengellé C, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(1): 81-6.


• 11. Bonnaud-Antignac A, Bourdon M (2017) La recherche en sciences humaines et sociales et les soins de support : Quelles articulations possibles? Exemples de la psycho-oncologie. Oncologie: in press.

2016

Articles dans une revue internationale

• 1. Gyan E, Andrieu V, Sanna A, Caille A, Schemenau J, Sudaka I, Siguret V, Malet M, Park S, Bordessoule D, Mairesse J, Gelsi-Boyer V, Cheze S, Beyne-Rauzy O, Sebert M, Sapena R, Zerazhi H, Legros L, Guerci-Bresler A, Amé S, et al (2016) Myelodysplastic syndromes with single neutropenia or thrombocytopenia are rarely refractory cytopenias with unilineage dysplasia by World Health Organization 2008 criteria and have favourable prognosis. Br J Haematol, 175(5): 975-9.


• 2. Caille A, Leyrat C, Giraudeau B (2016) A comparison of imputation strategies in cluster randomized trials with missing binary outcomes. Stat Methods Med Res, 25(6): 2650-69.


• 3. Machet L, Lanotte P, Giraudeau B, Leperlier M, Tavernier E, Maruani A (2016) Amber necklaces: reasons for use and awareness of risk associated with bacterial colonisation. Eur J Dermatol, 26(6): 580-5.


• 4. Cornillier H, Kervarrec T, Tabareau-Delalande F, Mammou S, Jonville-Bera AP, Machet L (2016) Interstitial granulomatous dermatitis occurring in a patient with SAPHO syndrome one month after starting leflunomide, and subsequently disappearing with ustekinumab. Eur J Dermatol, 26(6): 614-5.


• 5. Rouquette A, Hardouin JB, Coste J (2016) Differential Item Functioning (DIF) ans subsequent bias in group comparisons using a composite measurement scale: a simulation study. Journal of Applied Measurement, 17(3): 312-334.


• 6. Lehur PA, Didnée AS, Faucheron JL, Meurette G, Zerbib P, Siproudhis L, Vinson-Bonnet B, Dubois A, Casa C, Hardouin JB, Durand-Zaleski I (2016) Cost-Effectiveness of New Surgical Treatments for Hemorrhoidal Disease: A Multicentre Randomized Controlled Trial Comparing Transanal Doppler-guided Hemorrhoidal Artery Ligation With Mucopexy and Circular Stapled Hemorrhoidopexy. Annals of surgery, 264(5): 710-716.


• 7. Agier MS, Boivin N, Maruani A, Giraudeau B, Gouraud A, Haramburu F, Jean-Pastor M, Machet L, Jonville-Bera AP (2016) Risk assessment of drug-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a disproportionality analysis using the French Pharmacovigilance Database. Br J Dermatol, 175(5): 1067-9.


• 8. Rousselet M, Guerineau B, Paruit M, Guinot M, Lise S, Destrube B, Ruffio-Thery S, Dominguez N, Brisseau-Gimenez S, Dubois V, Mora C, Trolonge S, Lambert S, Grall-Bronnec M, Pretagut S (2016) Disordered eating in French high-level athletes: association with type of sport, doping behaviour, and psychological features. Eating and Weight disorders: .


• 9. Gailledrat L, Rousselet M, Vénisse JL, Lambert S, Rocher B, Remaud M, Guilleux A, Sauvaget A, Eyzop E, Grall-Bronnec M (2016) Marked Body Shape Concerns in Female Patients Suffering from Eating Disorders: Relevance of a Clinical Sub-group. . Plos One, 11(10): e0165232.


• 10. Romo L, Legauffre C, Guilleux A, Valleur M, Magalon D, Fatseas M, Chéreau-Boudet I, Luquiens A, Vénisse JL, JEU Group , Grall-Bronnec M, Challet G (2016) Cognitive distortions and ADHD in pathological gambling: A national longitudinal case-control cohort study. J Behav Addict, 5(4): 649-57.


• 11. Wéry A, Vogelaere K, Challet G, Poudat FX, Caillon J, Lever D, Billieux J, Grall-Bronnec M (2016) Characteristics of self-identified sexual addicts in a behavioral addiction outpatient clinic. J Behav Addict, 5(4): 623-30.


• 12. Kaguelidou F, Beau-Salinas F, Jonville-Bera AP, Jacqz-Aigrain E (2016) Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database. Br J Clin Pharmacol, 82(4): 1058-68.


• 13. Etcheverrigaray F, Betaud C, Feuillet F, Grall-Bronnec M, Jolliet P, Victorri-Vigneau C (2016) Pharmacists’ different profiles characterization about opioid substitution treatments. Therapie, 71: 379-387.


• 14. Roux H, Ali A, Lambert S, Radon L, Huas C, Curt F, Berthoz S, Godart N, EVHAN G (2016) Predictive factors of dropout from inpatient treatment for anorexia nervosa. BMC Psychiatry, 15(1): 339.


• 15. Challet G, Hardouin JB, Lagadec M, Burlacu S, Valleur M, Magalon D, Fatseas M, Chéreau-Boudet I, Gorsane MA, Vénisse JL, Grall-Bronnec M (2016) Profiles of problem and non-problem gamblers, depending on their preferred gambling activity. Addiction Research & Theory, 24(3): 209-222.


• 16. De Seta D, N'guyen Y, Vanier A, Ferray E, Bebear J, Godey B, Robier A, Mondain M, Deguine O, Sterkers O, Mosnier I (2016) Five-Year Hearing Outcomes in Bilateral Simultaneously Cochlear-Implanted Adult Patients. Audiology Neurotology, 21: 261-67.


• 17. Chaumier F, Gyan E, Vallet N, Hérault B, Mallet D (2016) Acute Myeloblastic Leukemia in the Elderly: How Could Palliative Care Teams and Hematologists Better Work Together?. J Palliat Med, 19(9): 906-7.


• 18. Rouquette A, Côté SM, Hardouin JB, Falissard B (2016) Rasch modelling to deal with changes in the questionnaires used during long-term follow-up of cohort studies: a simulation study.. BMC Med Res Methodol, 16(1): 105.


• 19. Boels D, Grall-Bronnec M, Guerlais M, Le Roux G, Spiers A, Gerardin M, Lomenech H, Bretaudeau M, Daveluy A, Turcant A, Jolliet P, Victorri-Vigneau C (2016) Parachuting: a dangerous trend in recreational psychoactive substance delivery. : [Epub ahead of print].


• 20. Morel A, Grall-Bronnec M, Bulteau S, Chauvin-Grelier P, Gailledrat L, PINOT ML, Jolliet P, Victorri-Vigneau C (2016) Benzodiazepine dependence in subjects with alcohol use disorders: what prevalence?. Expert Opin Drug Saf, 15(10): 1313-9.


• 21. Vourc’h M, Feuillet F, Mahé PJ, Sébille V, Asehnoune K (2016) Baclofen to prevent agitation in alcoholaddicted patients in the ICU: study protocol for a randomised controlled trial. Trials, 17(1): 415.


• 22. Caille A, Kerry S, Tavernier E, Leyrat C, Eldridge S, Giraudeau B (2016) Timeline cluster: a graphical tool to identify risk of bias in cluster randomised trials. BMJ, 354: i4291.


• 23. Touhami S, Fardeau C, Vanier A, Zambrowski O, Steinborn R, Simon C, Tézenas du Montcel S, Bodaghi B, Le Hoang P (2016) Birdshot Retinochoroidopathy: Prognostic Factors of Long-term Visual Outcome. Americal Journal of Ophthalmology: [Epub ahead of print].


• 24. Bourdon M, Blanchin M, Tessier P, Campone M, Quéreux G, Dravet F, Sébille V, Bonnaud-Antignac A (2016) Changes in quality of life after a diagnosis of cancer: A two-year study comparing breast cancer and melanoma patients. Quality of Life Research, 25(8): 1969-1979.


• 25. Blanchin M, Hardouin JB, Bonnaud-Antignac A, Sébille V (2016) Analysis of longitudinal patient reported outcomes data with Classical Test Theory and Rasch-based methods: an application on health-related quality of life in breast cancer patients. Statistica Applicata – Italian Journal of Applied Statistics, 27(1): 41-56.


• 26. Sautenet B, Contentin L, Bigot A, Giraudeau B (2016) Strong heterogeneity of outcome reporting in systematic reviews. J Clin Epidemiol, 75: 93-9.


• 27. Hamel JF, Sébille V, Challet G, Hardouin JB (2016) Partial Credit Model: estimations and tests of fit with pcmodel. Stata Journal, 16(2): 464-481.


• 28. Péron E, Hardouin JB, Feuillet F, Wainstein L, Chaslerie A, Pivette J, Jolliet P, Victorri-Vigneau C (2016) Selective Serotonin Reuptake Inhibitors, are they all the same? a pharmacoepidemiological approach . Advances in Pharmacoepidemiology and Drug Safety, 5(3): 1000203.


• 29. Challet G, Perrot B, Romo L, Valleur M, Magalon D, Fatseas M, Chéreau-Boudet I, Luquiens A, JEU Group , Grall-Bronnec M, Hardouin JB (2016) Harmonizing screening for gambling problems in epidemiological surveys - development of the Rapid Screener for Problem Gambling (RSPG). Journal of Behavioral Addictions, 5(2): 239–250.


• 30. Tavernier E, Trinquart L, Giraudeau B (2016) Finding Alternatives to the Dogma of Power Based Sample Size Calculation: Is a Fixed Sample Size Prospective Meta-Experiment a Potential Alternative?. PloS One, 11(6): e0158604.


• 31. Winterfeld U, Merlob P, Baud D, Rousson V, Panchaud A, Rothuizen L, Bernard N, Vial T, Yates L, Pistelli A, Ellfolk M, Eleftheriou G, de Vries L, Jonville-Bera AP, Kadioglu M, Biollaz J, Buclin T (2016) Pregnancy outcome following maternal exposure to pregabalin may call for concern. Neurology, 86(24): 2251-7.


• 32. Victorri-Vigneau C, Hardouin JB, Rousselet M, Gérardin M, Guerlais M, Guillou-Landreat M, Grall-Bronnec M, Sébille V, Jolliet P, and the French Addictovigilance network (2016) Multicentre study for the validation of the French addictovigilance network reports assessment tool. British Journal of Clinical Pharmacology, 82: 1030-1039.


• 33. Blanchin M, Sébille V, Guilleux A, Hardouin JB (2016) The Guttman errors as a tool for response shift detection at subgroup and item levels. Quality of Life Research, 25(6): 1385-1393.


• 34. Ali A, Carré A, Hassler C, Spilka S, Vanier A, Barry C, Berthoz S (2016) Risk factors for substances use and misuse among young people in France: What can we learn from the Substance Use Risk Profile Scale?. Drug and Alcohol Dependence, 163: 84-91.


• 35. Deumier L, Alliot-Licht B, Boutin-Kelly L, Bonnaud-Antignac A, Michaud C, Quillot F, Guihard G (2016) Factor analysis of a motivation questionnaire adapted to predoctoral French dental students. Journal of Dental Sciences, 11(2): 123–129.


• 36. Nadal M, Giraudeau B, Tavernier E, Jonville-Bera AP, Lorette G, Maruani A (2016) Efficacy and Safety of Mammalian Target of Rapamycin Inhibitors in Vascular Anomalies: A Systematic Review. Acta Derm Venereol, 96(4): 448-52.


• 37. Chaumier F, Touzet L, Olivereau S, Mallet D (2016) Prevalence of Palliative Patients with Cancer Treatment and High Levels of Discomfort in a French Cancer Center: Is There a Paradox?. J Palliat Med, 19(5): 477-8.


• 38. Grall-Bronnec M, Caillon J, Humeau E, Perrot B, Remaud M, Guilleux A, Rocher B, Sauvaget A, Challet G (2016) Gambling among European professional athletes. Prevalence and associated factors. Journal of Addictive Diseases, 35(4): 278-290.


• 39. Victorri-Vigneau C, Rousselet M, Grall-Bronnec M, Bouquié R, Belliot E, Guerlais M, Guillet JY, Jolliet P (2016) Use of Psychotropic Drug Urine Test Strips in Opiate Maintenance Therapy: A Clinical Assessment of Its Advantages. Substance Abuse, 37(4): 584-90.


• 40. Guillou-Landreat M, Guilleux A, Sauvaget A, Brisson L, Leboucher J, Remaud M, Challet G, Grall-Bronnec M (2016) Factors associated with suicidal risk among a French cohort of problem gamblers seeking treatment. Psychiatry Research, 240: 11-18.


• 41. Ouldamer L, Bonastre J, Brunet-Houdard S, Body G, Giraudeau B, Caille A (2016) Dead space closure with quilting suture versus conventional closure with drainage for the prevention of seroma after mastectomy for breast cancer (QUISERMAS): protocol for a multicentre randomised controlled trial. BMJ Open, 6(4): e009903.


• 42. Roquilly A, Feuillet F, Seguin P, Lasocki S, Cinotti R, Launey Y, Thioliere L, Le Floch R, Mahé PJ, Nesseler N, Cazaubiel T, Rozec B, Lepelletier D, Sébille V, Mallédant Y, Asehnoune K (2016) Empiric antimicrobial therapy for ventilator-associated pneumonia after brain injury. Eur Respir J, 47(4): 1219-28.


• 43. Le Borgne F, Giraudeau B, Querard AH, Giral M, Foucher Y (2016) Comparisons of the performance of different statistical tests for time-to-event analysis with confounding factors: practical illustrations in kidney transplantation. Stat Med, 35(7): 1103-16.


• 44. Fatseas M, Alexandre JM, Vénisse JL, Romo L, Valleur M, Magalon D, Chéreau-Boudet I, Luquiens A, Guilleux A, JEU Group , Challet G, Grall-Bronnec M (2016) Gambling behaviors and psychopathology related to attention-deficit/hyperactivity disorder (ADHD) in problem and non-problem adult gamblers?. Psychiatry Research, 239: 232-8.


• 45. Porcher R, Leyrat C, Baron G, Giraudeau B, Boutron I (2016) Performance of principal scores to estimate the marginal compliers causal effect of an intervention. Stat Med, 35(5): 752-67.


• 46. Raffin D, Giraudeau B, Samimi M, Machet L, Pourrat X, Maruani A (2016) Corticosteroid Phobia Among Pharmacists Regarding Atopic Dermatitis in Children: A National French Survey. Acta Derm Venereol., 96(2): 177-80.


• 47. Bemer P, Léger J, Tandé D, Plouzeau C, Valentin A, Jolivet-Gougeon A, Lemarié C, Kempf M, Héry-Arnaud G, Bret L, Juvin M, Giraudeau B, Corvec S, Burucoa C, Gaborin L, GRIOGO Study Team (2016) How Many Samples and How Many Culture Media To Diagnose a Prosthetic Joint Infection: a Clinical and Microbiological Prospective Multicenter Study. J Clin Microbiol, 54(2): 385-91.


• 48. Grall-Bronnec M, Sauvaget A, Perrouin F, Leboucher J, Etcheverrigaray F, Challet G, Gaboriau L, Jolliet P, Victorri-Vigneau C (2016) Pathological gambling associated with aripiprazole or dopamine replacement therapy: do patients share the same features? A review. Journal of Clinical Psychopharmacology, 36(1): 63-70.


• 49. Cinotti R, Piriou N, Launey Y, Le Tourneau T, Lamer M, Delater A, Trochu JN, Brisard L, Lakhal K, Bourcier R, Desal H, Seguin P, Mallédant Y, Blanloeil Y, Feuillet F, Asehnoune K, Rozec B (2016) Speckle tracking analysis allows sensitive detection of stress cardiomyopathy in severe aneurysmal subarachnoid hemorrhage patients. Intensive Care Med, 42(2): 173-82.


• 50. Fournier MC, Foucher Y, Blanche P, Buron F, Giral M, Dantan E (2016) A joint model for longitudinal and time-to-event data to better assess the specific role of donor and recipient factors on long-term kidney transplantation outcomes. European Journal of Epidemiology: .


• 51. Giraudeau B, Higgins J, Tavernier E, Trinquart L (2016) Sample size calculation for meta-epidemiological studies.. Stat Med, 35(2): 239-50.


• 52. Barbin L, Rousseau C, Jousset N, Casey R, Debouverie M, Vukusic S, De Seze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Tourbah A, Stankoff B, Foucher Y, Laplaud D (2016) Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study. Neurology: .


• 53. Bruneau M, Grall-Bronnec M, Vénisse JL, Romo L, Valleur M, Magalon D, Fatseas M, Chéreau-Boudet I, Luquiens A, JEU Group , Challet G, Hardouin JB (2016) Gambling transitions among adult gamblers: A multi-state model using a Markovian approach applied to the JEU cohort. Addictive Behaviors, 57: 13-20.


• 54. Leyrat C, Caille A, Foucher Y, Giraudeau B (2016) Propensity score to detect baseline imbalance in cluster randomized trials: the role of the c-statistic. BMC Med Res Methodol, 16: 9.


• 55. Sébille V, Hardouin JB, Giral M, Bonnaud-Antignac A, Tessier P, Papuchon E, Jobert A, Faurel-Paul E, Gentile S, Cassuto R, Morelon E, Rostaing L, Glotz D, Sberro-Soussan R, Foucher Y, Meurette A (2016) Prospective, multicenter, controlled study of quality of life, psychological adjustment process and medical outcomes of patients receiving a preemptive kidney transplant compared to a similar population of recipients after dialysis. BMC Nephrol, 17(1): 11.


• 56. Dannepond C, Ternant D, Maruani A, Machet L, Paintaud G, Samimi M (2016) Serum infliximab concentrations and disease activity: a descriptive study of patients with psoriasis. Br J Dermatol, 174(1): 198-200.


• 57. Guillet A, Connault J, Perrot P, Perret C, Herbreteau D, Berton M, Caron V, Aubert H, Stalder J, Maruani A, Barbarot S (2016) Early symptoms and long-term clinical outcomes of distal limb's cutaneous arterio-venous malformations: a retrospective multicentre study of 19 adult patients. J Eur Acad Dermatol Venereol, 30(1): 36-40.


• 58. Zaragoza J, Caille A, Beneton N, Bens G, Christiann F, Maillard H, Machet L (2016) High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma. Br J Dermatol, 174(1): 146-51.


• 59. Querard AH, Foucher Y, Combescure C, Dantan E, Larmet D, Lorent M, Pouteau LM, Giral M, Gillaizeau F (2016) Comparison of survival outcomes between Expanded Criteria Donors and Standard Criteria Donors kidney transplant recipients: a systematic review and meta-analysis. Transplant International: .


• 60. Brédart A, Merdy O, Sigal-Zafrani B, Fiszer C, Dolbeault S, Hardouin JB (2016) Identifying trajectory clusters in breast cancer survivors' supportive care needs, psychosocial difficulties, and resources from the completion of primary treatment to 8 months later.. Supportive Care in Cancer, 24(1): 357-366.


• 61. Dantan E, Foucher Y, Lorent M, Giral M, Tessier P (2016) Optimal threshold estimator of a prognostic marker by maximizing a time-dependent expected utility function for a patient-centered stratified medicine. Statistical Methods in Medical Research: 1-13.


• 62. Clobert M, Van Cappellen P, Bourdon M, Cohen AB (2016) Good day for Leos: Horoscope's influence on perception, cognitive performances, and creativity. Personality and Individual Differences, 101: 348-355.

Chapitres d'ouvrage

• 1. Bonnaud-Antignac A, Bourdon M, Tessier P, Sébille V, Blanchin M, Dravet F, Quéreux G (2016) Qualité de vie et changements psychologiques pendant et après les traitements d'un cancer du sein ou d'un mélanome. In Evolutions sociales, Innovations et politiques : Nouveaux enjeux en psychologie de la santé (AM Etienne et I Bragard): Editions des archives contemporaines.

Articles dans une revue nationale

• 1. Eyzop E, Vénisse JL, Grall-Bronnec M (2016) Prendre en compte la motivation dans un parcours en addictologie. A partir de l'exemple du trouble lié à la pratique des jeux de hasard et d'argent. Presse Med., 45(12): 1147-53.


• 2. Agier MS, Lengellé C, Bejan-Angoulvant T, Beau-Salinas F, Jonville-Bera AP (2016) [Drugs news]. Arch Pediatr, 23(11): 1204-16.


• 3. Simon C, Agier MS, Béné J, Muller C, Vrignaud L, Marret H, Jonville-Bera AP (2016) [Safety profile of etonogestrel contraceptive implant (Nexplanon® and Implanon®) reported in France]. J Gynecol Obstet Biol Reprod, 45(9): 1074-82.


• 4. Agier MS, Beau-Salinas F, Lengellé C, Bejan-Angoulvant T, Jonville-Bera AP (2016) [Drugs news]. Arch Pediatr, 23(9): 1002-5.


• 5. Jonville-Bera AP, Mallaret M, Sgro C, Association Française des Centres Régionaux de Pharmacovigilance (2016) [The congress of the French Society of Pharmacology and Therapeutics celebrate in Nancy, 20 April 2016, 40 years of French Regional Pharmacovigilance Centres!]. Thérapie, 71(4): 351-4.


• 6. Pottier P, Castillo J, Boet S, Le Pabic E, Hardouin JB (2016) Validation of a questionnaire for standardized-patient assessment of clinical skills. Revue de Médecine Interne: in press.


• 7. Beau-Salinas F, Lengellé C, Bejan-Angoulvant T, Agier MS, Jonville-Bera AP (2016) [Drugs news]. Arch Pediatr, 23(6): 646-52.


• 8. Jonville-Bera AP, Vial T, Sgro C, Mallaret M, Association Française des Centres Régionaux de Pharmacovigilance (2016) [On the absence of reimbursement of rotavirus vaccine in France]. Arch Pediatr, 23(6): 655-7.


• 9. Etcheverrigaray F, Betaud C, Grall-Bronnec M, Jolliet P, Victorri-Vigneau C (2016) Caractérisation des différents profils de pharmaciens vis-à-vis des traitements de substitution aux opiacés. : in press.

Thèses/Rapports/Mémoires

• 1. Vanier A (2016) Thèse de science biostatistique - Université de Nantes. The concept, measurement and integration of response shift phenomenon in Patient-Reported Outcomes data analyses. On certain methodological and statistical considerations. , 174 pages.

2015

Articles dans une revue internationale

• 1. Gross R, Leboeuf F, Hardouin JB, Perrouin-Verbe B, Brochard S, Remy-Neris O (2015) Does Muscle coactivation influence joint excursions during gait in children with and without hemiplegic cerebral palsy? Relationship between muscle coactivation and joint kinematics.. Clinical Biomechanics, 30(10): 1088-1093.


• 2. Batard E, Lecadet N, Goffinet N, Hardouin JB, CEFPU1 Study Group , Lepelletier D, Potel G, Montassier E (2015) High variability among Emergency Departments in 3rd-generation cephalosporins and fluoroquinolones use for community-acquired pneumonia.. Infection, 43(6): 681-689.


• 3. Boutoleau-Bretonnière C, Evrard C, Hardouin JB, Rocher L, Charriau T, Etcharry-Bouyx F, Auriacombe M, Richard-Mornas A, Lebert F, Pasquier F, Sauvaget A, Bulteau S, Vercelletto M, Derkinderen P, Boutoleau-Bretonnière C, Thomas R (2015) DAPHNE: a new tool for diagnosis of behavioral variant of frontototemporal dementia. Dement Geriatr Cogn Dis Extra, 5(3): 503-516.


• 4. Ouldamer L, Caille A, Giraudeau B, Body G (2015) Quilting Suture of Mastectomy Dead Space Compared with Conventional Closure with Drain. Ann Surg Oncol, 22(13): 4233-40.


• 5. Recipon G, Piver E, Caille A, Le Pape P, Pihet M, Pagès J, Chandenier J, Desoubeaux G (2015) Is procalcitonin increased in cases of invasive amoebiasis? A retrospective, observational study. Diagn Microbiol Infect Dis, 83(4): 395-9.


• 6. Dibao-Dina C, Lebeau JP, Huas D, Boutitie F, Pouchain D, French National College of Teachers in General Practice (2015) ESCAPE ancillary blood pressure measurement study 2: changes in end-digit preference after 2 years of a cluster randomized trial. Blood Press Monit, 20(6): 346-50.


• 7. Couvrat-Desvergnes G, Salama A, Le Berre L, Evanno G, Viklicky O, Hruba P, Vesely P, Guerif P, Dejoie T, Rousse J, Nicot A, Basch J, Ang E, Foucher Y, Brouard S, Castagnet S, Giral M, Perreault H, Lorent M, Soulillou JP (2015) Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival. J Clin Invest, 125(12): .


• 8. Duchalais E, Meurette G, Perrot B, Wyart V, Kubis C, Lehur PA (2015) Exhausted implanted pulse generator in sacral nerve stimulation for faecal incontinence: What next in daily practice for patients?. International Journal of Colorectal Disease: .


• 9. Hamel JF, Sébille V, Le Neel T, Kubis G, Boyer F, Hardouin JB (2015) What are the appropriate methods for analyzing patients reported outcomes in randomized trials when data are missing?. Statistical Methods in Medical Research: under press.


• 10. Gérardin M, Couec M, Grall-Bronnec M, Feuillet F, Wainstein L, Rousselet M, Perrouin F, Bonnot O, Drouineau MH, Jolliet P, Victorri-Vigneau C (2015) PHEDRE trial protocol – observational study of the prevalence of problematic use of Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) and analgesics in the French sickle-cell disease population. BMC Psychiatry, 15: 281.


• 11. Guillou-Landreat M, Rozaire C, Guillet JY, Victorri-Vigneau C, Le Reste J, Grall-Bronnec M (2015) French Experience with Buprenorphine : Do Physicians Follow the Guidelines?. PLOS ONE, 10(10): e0137708.


• 12. Duclay E, Hardouin JB, Sébille V, Anthoine E, Moret L (2015) Exploring the Impact of staff absenteism on patient satisfaction using routinely indicators in a university hospital. Journal of Nursing Management, 23(7): 833-841.


• 13. Sautenet B, Caille A, Giraudeau B, Léger J, Vourc'h P, Buchler M, Halimi JM (2015) Deficits in information transfer between hospital-based and primary-care physicians, the case of kidney disease: a cross-sectional study. J Nephrol, 28(5): 563-70.


• 14. Sauvaget A, Trojak B, Bulteau S, Jiménez-Murcia S, Fernández-Aranda F, Wolz I, Menchón JM, Achab S, Vanelle J, Grall-Bronnec M (2015) Transcranial direct current stimulation (tDCS) in behavioral and food addiction: a systematic review of efficacy, technical, and methodological issues. Front Neurosci, 9: 349.


• 15. Feddag ML, Sébille V, Blanchin M, Hardouin JB (2015) Estimation of parameters of the Rasch model and comparison of groups in presence of locally dependent items. Journal of Applied Measurement, 16(3): 268-77.


• 16. Le Fur A, Fournier MC, Gillaizeau F, Masson D, Giral M, Cariou B, Cantarovich D, Dantal J (2015) Vitamin D deficiency is an independent risk factor for PTDM after kidney transplantation.. Transplant international: .


• 17. Godart N, Radon L, Curt F, Duclos J, Perdereau F, Lang F, Vénisse JL, Halfon O, Bizouard P, Loas G, Corcos M, Jeammet P, Flament M (2015) Mood disorders in eating disorder patients: Prevalence and chronology of ONSET. J Affect Disord, 1(127): 115-22.


• 18. Touhami S, Fardeau C, Vanier A, Knoeri J, Simon C, Tézenas du Montcel S, Troumani Y, Bodaghi B, Le Hoang P (2015) Visual Acuity in Birdshot Retinochoroidopathy Evaluation. Americal Journal of Ophthalmology, 160(4): 817-21.


• 19. Barnes C, Boutron I, Giraudeau B, Porcher R, Altman D, Ravaud P (2015) Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial. BMC Med, 13(127): .


• 20. Droitcourt C, Boccara O, Fraitag S, Favrais G, Dupuy A, Maruani A (2015) Multifocal Lymphangioendotheliomatosis With Thrombocytopenia: Clinical Features and Response to Sirolimus. Pediatrics, 136(2): 517-22.


• 21. Dibao-Dina C, Caille A, Giraudeau B (2015) Unbalanced rather than balanced randomized controlled trials are more often positive in favor of the new treatment: an exposed and nonexposed study. J Clin Epidemiol, 68(8): 944-9.


• 22. Vanier A, Sébille V, Blanchin M, Guilleux A, Hardouin JB (2015) Overall performance of Oort's procedure for response shift detection at item-level: a pilot simulation study. Quality of life research, 24(8): 1799-807.


• 23. Blanchin M, Dauchy S, Cano A, Brédart A, Aaronson N, Hardouin JB (2015) Validation of the French translation-adaptation of the Impact of Cancer version 2 (IOCv2) questionnaire on a breast cancer survivors population. Health and Quality of Life Outcomes, 13: 110.


• 24. Guerlais M, Grall-Bronnec M, Feuillet F, Gérardin M, Jolliet P, Victorri-Vigneau C (2015) Dependence on prescription benzodiazépines and z-drugs among young to middle-aged patients in France. Subst Use Misuse, 50(3): 320-327.


• 25. Hardouin JB, Blanchin M, Feddag ML, Le Neel T, Perrot B, Sébille V (2015) Power and sample size determination for group comparison on Patient Reported Outcomes using polytomous Rasch models. Statistics in Medicine, 34(16): 2444-55.


• 26. Tavernier E, Giraudeau B (2015) Sample Size Calculation: Inaccurate A Priori Assumptions for Nuisance Parameters Can Greatly Affect the Power of a Randomized Controlled Trial. PLoS One, 10(7): e0132578.


• 27. Espitia O, Fouassier M, Hardouin JB, Pistorius MA, Planchon B, Trossaert M, Pottier P (2015) Thrombin generation assay in medical patients: a prospective study, on venous thrombosis risk factor.. Clinical and Applied Thrombosis/Hemostasis: under press.


• 28. Vanier A, Leplège A, Hardouin JB, Sébille V, Falissard B (2015) Semantic primes theory may be helpful in designing questionnaires such as to prevent response shift. Journal of Clinical Epidemiology, 68(6): 646-654.


• 29. Chapal M, Foucher Y, Marquette C, Néau K, Papuchon E, Daguin P, Morelon E, Mourad G, Castillo J, Ladrière M, Legendre C, Giral M (2015) PREventing Delayed Graft Function by Driving Immunosuppressive InduCtion Treatment (PREDICT-DGF): study protocol for a randomized controlled trial. Trials, 16(1): 282.


• 30. Feuillet F, Bellanger L, Hardouin JB, Victorri-Vigneau C, Sébille V (2015) On comparison of clustering methods for pharmacoepidemiological data. Journal of Biopharmaceutical Statistics, 25(4): 843-856.


• 31. Gillaizeau F, Dantan E, Giral M, Foucher Y (2015) A multistate additive relative survival semi-Markov model. Statistical Methods in Medical Research: pii: 0962280215586456 [Epub ahead of print].


• 32. Sauvaget A, Jiménez-Murcia S, Fernández-Aranda F, Fagundo AB, Moragas L, Wolz I, Veciana De Las Heras M, Granero R, Del Pino-Gutiérrez A, Baño M, Real E, Aymamí N, Grall-Bronnec M, Menchón JM (2015) Unexpected online gambling disorder in late-life: a case report. Front Psychol, 6: 655.


• 33. Caillon J, Grall-Bronnec M, Hardouin JB, Vénisse JL, Challet G (2015) Online gambling’s moderators: how effective? Study protocol for a randomized controlled trial. BMC Public Health, 15: 519.


• 34. Valleur M, Codina I, Vénisse JL, Romo L, Magalon D, Fatseas M, Chéreau-Boudet I, Gorsane MA, Guilleux A, JEU Group , Grall-Bronnec M, Challet G (2015) Towards a Validation of the Three Pathways Model of Pathological Gambling. J Gambl Stud, 32(2): 757-71.


• 35. Desmée S, Mentré F, Veyrat-Follet C, Guedj J (2015) Nonlinear Mixed-effect Models for Prostate-specific Antigen Kinetics and Link with Survival in the Context of Metastatic Prostate Cancer: A Comparison by Simulation of Two-stage and Joint Approaches. AAPS J, 17(3): 691-9.


• 36. Bulteau S, Etcheverrigaray F, Grall-Bronnec M, Loutrel O, Lejus C, Vanelle J, Victorri-Vigneau C, Sauvaget A (2015) Butyrylcholinesterase Atypical Mutation in a Patient Undergoing Electroconvulsive Therapy. J ECT, 32(2): e4-5.


• 37. Dany A, Barbe C, Morrone I, Wolak A, Reveillère C, Hardouin JB, Dramé M, Sacconi S, Bassez G, Tiffreau V, Richard I, Gallais B, Jolly D, Novella JL, Boyer F (2015) Construction of a Quality of Life Questionnaire for Slowly Progressive Neuromuscular Disease. Quality of Life Research: .


• 38. Legras A, Caille A, Begot E, Lhéritier G, Lherm T, Mathonnet A, Frat JP, Courte A, Martin-Lefebvre L, Gouëllo J, Mercier E, Vignon P, ARCO & CRICS Network (2015) Acute respiratory distress syndrome (ARDS)-associated acute cor pulmonale and patent foramen ovale: a multicenter noninvasive hemodynamic study. Crit Care, 19: 174.


• 39. Dannepond C, Maruani A, Machet L, Ternant D, Paintaud G, Samimi M (2015) Serum infliximab concentrations in psoriatic patients treated with infliximab: a systematic review. Acta Derm Venereol, 95(4): 401-6.


• 40. Marret H, Simon E, Beucher G, Dreyfus M, Gaudineau A, Vayssière C, Lesavre M, Pluchon M, Winer N, Fernandez H, Aubert J, Bejan-Angoulvan T, Jonville-Bera AP, Clouqueur E, Houfflin-Debarge V, Garrigue A, Pierre F, Collège National des Gynécologues Obstétriciens Français (2015) Overview and expert assessment of off-label use of misoprostol in obstetrics and gynaecology: review and report by the Collège national des gynécologues obstétriciens français. Eur J Obstet Gynecol Reprod Biol, 187: 80-4.


• 41. Grall-Bronnec M, Bulteau S, Victorri-Vigneau C, Challet G, Sauvaget A (2015) Fortune telling addiction: unfortunately a serious topic. About a case report. J Behav Addict, 4(1): 27-31.


• 42. Pottier P, Hardouin JB, Dejoie T, Castillo J, Le Loupps AG, Planchon B, Bonnaud-Antignac A, Leblanc V (2015) Effect of extrinsic and intrinsic stressors on measures of stress and clinical reasoning in medical students. Journal of General Internal Medicine: under press.


• 43. Blanchin M, Guilleux A, Perrot B, Bonnaud-Antignac A, Hardouin JB, Sébille V (2015) Power and sample size determination for the group comparison of patient-reported outcomes using the Rasch model: impact of a misspecification of the parameters. BMC Medical Research Methodology, 15: 21.


• 44. Delaplace M, Dumont P, Lorette G, Machet L, Lagier L, Maruani A, Samimi M (2015) Factors associated with long-term outcome of endoscopic thoracic sympathectomy for palmar hyperhidrosis: a questionnaire survey in a cohort of French patients. Br J Dermatol, 173(3): 205-7.


• 45. Dreyfus I, Pauwels C, Bourrat E, Bursztejn A, Maruani A, Chiaverini C, Maza A, Mallet S, Bessis D, Barbarot S, Ezzedine K, Vabres P, Mazereeuw-Hautier J (2015) Burden of inherited ichthyosis: a French national survey. Acta Derm Venereol, 95(3): 326-8.


• 46. Gouveia L, Lelorain S, Brédart A, Dolbeault S, Bonnaud-Antignac A, Cousson-Gélie F, Sultan S (2015) Oncologists’ perception of depressive symptoms in patients with advanced cancer: accuracy and relational correlates. BMC Psychology, 3(1): 6.


• 47. Guilleux A, Blanchin M, Vanier A, Guillemin F, Falissard B, Schwartz C, Hardouin JB, Sébille V (2015) RespOnse Shift ALgorithm in Item response theory (ROSALI) for response shift detection with missing data in patient-reported outcomes in longitudinal clinical studies. Quality of life research, 24(3): 553-564.


• 48. Grignon O, Montassier E, Corvec S, Lepelletier D, Hardouin JB, Caillon J, EDBAC Study Group , Batard E (2015) Escherichia coli antibiotic resistance in Emergency Departments. Do local resistance rates matter ?. European Journal of Clinical Microbiology and Infectious Diseases, 34(3): 571-577.


• 49. Lasocki S, Meyer C, Le Gouil S, Boulic M, Bousquet PJ, Belliot E, Attal M, Frat JP, Denou F, Gouëllo J, Delahousse M, Hruba P, Chaillou L, Pichot E, Desal H, Belliard G, Thervet E, Quenon JL, Simonneau F, Labarriere N, Plantefeve G, Vivier D, Girardie P, Giraudeau B, Reignier J (2015) Therapeutic hypothermia after nonshockable cardiac arrest: the HYPERION multicenter, randomized, controlled, assessor-blinded, superiority trial. Scand J Trauma Resusc Emerg Med, 23: 26.


• 50. Bouquié R, Hernando H, Deslandes G, Ben Mostefa Daho A, Renaud C, Grall-Bronnec M, Dailly E, Jolliet P (2015) Chiral on-line solid phase extraction coupled to liquid chromatography-tandem mass spectrometry assay for quantification of (R) and (S) enantiomers of methadone and its main metabolite in plasma. Talanta, 134: 373-378.


• 51. Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, Phillips R, Caceres H, Lopez Gutierrez J, Ballona R, Friedlander S, Powell J, Perek D, Metz B, Barbarot S, Maruani A, Szalai Z, Krol A, Boccara O, Foelster-Holst R, Febrer Bosch ML, Su J, Bu A (2015) A randomized, controlled trial of oral propranolol in infantile hemangioma. N Eng J Med, 372(8): 735-46.


• 52. le Fourn E, Herbreteau D, Papagiannaki C, Lorette G, Sirinelli D, Goga G, Maruani A (2015) Efficacy and safety of embolization in arteriovenous malformations of the extremities and head and neck: a retrospective study of 32 cases. Eur J Dermatol, 25(1): 52-6.


• 53. Berton M, Lorette G, Baulieu F, Lagrue E, Blesson S, Cambazard F, Vaillant L, Maruani A (2015) Generalized lymphedema associated with neurologic signs (GLANS) syndrome: a new entity?. J Am Acad Dermatol, 72(2): 333-9.


• 54. Cloix L, Caille A, Helmer C, Bourdel-Marchasson I, Fagot-Campagna A, Fournier C, Lecomte P, Oppert J, Jacobi D (2015) Physical activity at home, at leisure, during transportation and at work in French adults with type 2 diabetes: the ENTRED physical activity study. Diabetes Metab, 41(1): 37-44.


• 55. Gardair C, Samimi M, Touzé A, Coursaget P, Lorette G, Caille A, Wierzbicka E, Croué A, Avenet-Audran M, Aubin F, Kerdraon R, Estève E, Beneton N, Guyétant S (2015) Somatostatin Receptors 2A and 5 Are Expressed in Merkel Cell Carcinoma with No Association with Disease Severity. Neuroendocrinology, 101(3): 223-35.


• 56. Béné J, Miremont-Salamé G, Perault-Pochat M, Nomine C, Haramburu F, EMIR Study Group on behalf of the French Network of Pharmacovigilance Centres (2015) Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study. Fundam Clin Pharmacol, 29(1): 106-11.


• 57. Foucher Y, Meurette A, Daguin P, Bonnaud-Antignac A, Hardouin JB, Néau K, Papuchon E, Guaboriau S, Legendre C, Morelon E, Tessier P, Giral M (2015) A Personalized Follow-up of Kidney Transplant Recipients by Using Video Conferencing based on a 1-year scoring system predictive of long term graft failure (TELEGRAFT study): Protocol for a Randomized Controlled Trial. BMC Nephrology, 16(1): 6.


• 58. Alexandre JM, Fatseas M, Challet G, Legauffre C, Valleur M, Magalon D, Chéreau-Boudet I, Gorsane MA, Auriacombe M, Hardouin JB, Vénisse JL, Grall-Bronnec M (2015) Gambling behavior among gamblers with and without attention deficit/hyperactivity disorder. Drug and Alcohol Dependence, 146: e205–e206.


• 59. Maruani A, Samimi M, Lorette G, Le Cleach L (2015) Comparative effectiveness of topical drugs in dermatologic priority diseases: geometry of randomized trial networks. J Invest Dermatol, 135(1): 76-83.


• 60. de Bock E, Hardouin JB, Blanchin M, Le Neel T, Kubis G, Sébille V (2015) Assessment of score and Rasch-based methods for group comparison of longitudinal Patient-Reported Outcomes with intermittent missing data (informative and non-informative). Quality of Life Research, 24(1): 19-29.


• 61. Wainstein L, Bernier C, Gérardin M, Bouquié R, Espitia O, Mussini J, Jolliet P, Victorri-Vigneau C (2015) Livedo-like dermatitis and necrotic lesions after high-dose buprenorphine injections : a national French survey. Brit J Dermatol, 172: 10412-4.


• 62. Jiménez-Murcia S, Granero R, Tárrega S, Angulo A, Fernández-Aranda F, Arcelus J, Fagundo AB, Aymamí N, Moragas L, Sauvaget A, Grall-Bronnec M, Gómez-Peña M, Menchón JM (2015) Mediational Role of Age of Onset in Gambling Disorder, a Path Modeling Analysis. J Gambl Stud: published online: .


• 63. Jézéquel P, Loussouarn D, Guérin-Charbonnel C, Campion L, Vanier A, Gouraud W, Hamza L, Guette C, Valo I, Verrièle V, Campone M (2015) Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response. Breast Cancer Research, 17: 43.

Articles dans une revue nationale

• 1. Sautenet B, Halimi JM, Caille A, Giraudeau B (2015) [Outcomes in randomized trials: Typology, relevance and importance for their standardization. Example of renoprotection]. Presse Med, 44(11): 1096-102.


• 2. Lengellé C, Bejan-Angoulvant T, Beau-Salinas F, Jonville-Bera AP (2015) [Drugs news]. Arch Pediatr, 22(11): 1200-6.


• 3. Dibao-Dina C, Caille A, Giraudeau B (2015) [Care and research: Are they ethically compatible?]. Presse Med, 44(11): 986-90.


• 4. Maruani A, Carriot M, Jonville-Bera AP, Lorette G, Gissot V, association Recommandations en Dermatologie (aRED) (2015) [Highlight on clinical research in pediatrics]. Ann Dermatol Venereol, 142(6): 446-9.


• 5. Bejan-Angoulvant T, Crochet J, Jonville-Bera AP (2015) [Calcium channel blockers pharmacology and their use as tocolytics]. J Gynecol Obstet Biol Reprod, 44(4): 305-11.


• 6. Beau-Salinas F, Lengellé C, Bejan-Angoulvant T, Jonville-Bera AP (2015) [Drugs news]. Arch Pediatr, 22(4): 440-6.


• 7. Legras A, Caille A, Diot P, Magro P (2015) [Echocardiography and pulmonary hypertension: experience of the competence centre in Tours, France]. Rev Mal Respir, 32(3): 301-3.


• 8. Lagadec M, Poudat FX, Grall-Bronnec M (2015) Addictions sexuelles: une expérience de TCC. Santé Mentale, 196: 72-77.


• 9. Bejan-Angoulvant T, Beau-Salinas F, Lengellé C, Cissoko H, Jonville-Bera AP (2015) [Drugs news]. Arch Pediatr, 22(2): .


• 10. Moret L, Anthoine E, Paillé C, Delmas C, et le Consortium CLARTE (2015) Projet national CLARTE : expérimentation et validation d’un panel d’indicateurs d’absentéisme et de turn-over hospitalier. Journal d’économie et de gestion médicale: .


• 11. Prud'homme S, Dufresne M, Abbey H, Paillé C, Leclère B, Moret L (2015) Annonce d’un événement indésirable grave lié aux soins : état des lieux des pratiques des médecins dans un hôpital universitaire. Presse médicale: .


• 12. Bonnaud-Antignac A, Tessier P, Nazih F, Quere M, Sébille V, Hardouin JB (2015) Stress, Qualité de vie et Santé des étudiants Suivi de cohortes en Première Année Commune d’Etude en Santé (PACES). Jounal de thérapie cognitive et comportementale: in press.


• 13. Bonnaud-Antignac A, Bourdon M, Dravet F (2015) Cancer du sein et chirurgie ambulatoire : une enquête exploratoire sur les facteurs qui motivent les patientes à faire ce choix. Oncologie, 17(1): 33-37.


• 14. Bonnaud-Antignac A, Bourdon M, Dréno B, Quéreux G (2015) Stratégies de coping mises en place au moment du diagnostic d’un mélanome : quels liens avec la qualité de vie deux ans plus tard ? . Annales de Dermatologie et de Vénéréologie, 142(12): S648-S649.


• 15. Bonnaud-Antignac A, Bourdon M, Roussiau N, Dréno B, Quéreux G (2015) Étude des changements spirituels suite au diagnostic d’un mélanome. Annales de Dermatologie et de Vénéréologie, 142(12): S651-S652.

2014

Articles dans une revue internationale

• 1. Launey Y, Nesseler N, Le Cousin A, Feuillet F, Garlantezec R, Mallédant Y, Seguin P (2014) Effect of a fever control protocol-based strategy on ventilator-associated pneumonia in severely brain-injured patients. Critical Care, 18(6): 689.


• 2. Anthoine E, Moret L, Regnault A, Sébille V, Hardouin JB (2014) Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures. Health and Quality of Life Outcomes, 12: 176.


• 3. Senage T, Le Tourneau T, Foucher Y, Pattier S, Michel M, Mugniot A, Perigaud C, Carton F, Al Habash O, Baron O, Roussel J (2014) Early Structural Valve Deterioration of Mitroflow aortic bioprosthesis : mode, incidence and impact on outcome in a large cohort of patients. Circulation, 130(23): 2012-20.


• 4. Montassier E, Corvec S, Hardouin JB, Potel G, Batard E (2014) Use of fluoroquinolones and 3rd-generation cephalosporins in the Emergency Department: a 11-year survey. European Journal of Emergency Medicine, 21(6): 442-446.


• 5. Chapal M, Le Borgne F, Legendre C, Kreiss H, Mourad G, Garrigue V, Morelon E, Buron F, Rostaing L, Kamar N, Kessler M, Ladrière M, Soulillou JP, Launay K, Daguin P, Offredo L, Giral M, Foucher Y (2014) A useful scoring system for the prediction and management of delayed graft function following kidney transplantation from cadaveric donors. Kidney International, 86(6): 1130-9.


• 6. Le Bourgeois A, Labopin M, Guillaume T, Foucher Y, Tessoulin B, Malard F, Ayari S, Peterlin P, Derenne S, Herry P, Cesbron A, Gagne K, Lodé L, Illiaquer M, Imbert-Marcille B, Le Gouil S, Moreau P, Mothy M, Chevallier P (2014) HHV-6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults. Experimental Hematology, 42(11): 945-54.


• 7. Moret L, Pourreau A, Anthoine E, Delmas C, Beaudeau F, Lombrail P (2014) Inpatients’ deprivation and their perceived social distance with physicians and nurses impact the quality and accessibility to medical information. Patient Education and Counseling: .


• 8. Anthoine E, Coutherut J, Delmas C, Moret L (2014) Facilitators and barriers of interprofessional collaboration regarding of perceived practices of sharing medical information and team communication. Journal of Interprofessional Care: .


• 9. Grall-Bronnec M, Sauvaget A (2014) The use of repetitive transcranial magnetic stimulation for modulating craving and addictive behaviours: A critical literature review of efficacy, technical and methodological considerations. Neuroscience and Biobehavioral Reviews, 47: 592–613.


• 10. Dibao-Dina C, Caille A, Sautenet B, Chazelle E, Giraudeau B (2014) Rationale for unequal randomization in clinical trials is rarely reported: a systematic review. J Clin Epidemiol, 67(10): 1070-5.


• 11. Blanchard C, Mathonnet M, Sebag F, Caillard C, Kubis C, Drui D, Van der Nuvel E, Ansquer C, Henry JF, Masson D, Kraeber-Bodéré F, Hardouin JB, zarnegar R, Hamy A, Mirallié E (2014) Quality of life is modestly improved in older patients with mild primary hyperparathyroidism postoperatively Results of a prospective multicenter study. Annals of Surgical Oncology, 21(11): 3534-3540.


• 12. Debout A, Foucher Y, Trébern-Launay K, Legendre C, Kreiss H, Mourad G, Garrigue V, Morelon E, Buron F, Rostaing L, Kamar N, Kessler M, Ladrière M, Poignas A, Blidi A, Soulillou JP, Giral M, Dantan E (2014) Each additional hour of Cold Ischemia Time significantly increases the risk of graft failure and mortality after renal transplantation. Kidney International, 87: 343-9.


• 13. Montassier E, Hardouin JB, Segard J, Batard E, Trochu JN, Planchon B, Potel G, Pottier P (2014) E-learning versus lecture-based courses in ECG interpretation for undergraduate medical students: a randomised non-inferiority study . European Journal of Emergency Medecine: under press.


• 14. Panouillères M, Anota A, Nguyen T, Brédart A, Bosset J, Monnier A, Mercier M, Hardouin JB (2014) Evaluation properties of the French version of the OUT-PATSAT35 satisfaction with care questionnaire according to classical and item response theory analyses. Quality of life Research, 23(7): 2089-2101.


• 15. Challet G, Hardouin JB, Renard N, Legauffre C, Valleur M, Magalon D, Fatseas M, Chéreau-Boudet I, Gorsane MA, Vénisse JL, JEU Group , Grall-Bronnec M (2014) A gamblers clustering based on their favourite gambling activity. Journal of Gambling Studies: published online.


• 16. Cinotti R, Ichai C, Orban JC, Kalfon P, Feuillet F, Roquilly A, Riou B, Blanloeil Y, Asehnoune K, Rozec B (2014) Effects of tight computerized glucose control on neurological outcome in severely brain injured patients: a multicenter sub-group analysis of the randomized-controlled open-label CGAO-REA study. Critical Care, 18(5): 498.


• 17. Rabot N, Buchler M, Foucher Y, Moreau A, Debiais C, Machet M, Kessler M, Morelon E, Thierry A, Legendre C, Rivalan J, Kamar N, Dantal J (2014) CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality. Transplant Internationnal, 27(9): 956-65.


• 18. Rezvani M, Challet G, Keriven-Dessomme B, Moret L, Grall-Bronnec M (2014) Workaholism: are physicians at risk?. Occup Med (Lond), 64(6): 410-6.


• 19. Asehnoune K, Seguin P, Allary J, Feuillet F, Lasocki S, Cook F, Floch H, Chabanne R, Geeraerts T, Roger C, Perrigault P, Hanouz J, Lukaszewicz A, Biais M, Boucheix P, Dahyot-Fizelier C, Capdevila X, Mahé PJ, Maguet P, Paugam-Burtz C, Gergaud S, Plaud B, Constantin JM, Malledant Y, Flet L, Sebille V, Roquilly A (2014) Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial. Lancet Respir Med, 2(9): 706-16.


• 20. Gérardin M, Victorri-Vigneau C, Guerlais M, Guillou-Landreat M, Grall-Bronnec M, Jolliet P (2014) Benzodiazepines consumption: does dependence vary with age?. Subst Use Misuse, 49(1): 1417-25.


• 21. Challet G, Hardouin JB, Vénisse JL, Romo L, Valleur M, Magalon D, Fatseas M, Chéreau-Boudet I, Gorsane MA, JEU Group , Grall-Bronnec M (2014) Study Protocol: the JEU cohort study – transversal multiaxial evaluation and 5-year follow-up of a cohort of French gamblers. BMC Psychiatry, 14: 226.


• 22. Yap M, Boeffard F, Clave E, Pallier A, Danger R, Giral M, Dantal J, Foucher Y, Guillot-Gueguen C, Toubert A, Soulillou JP, Degauque N (2014) Expansion of Highly Differentiated Cytotoxic Terminally Differentiated Effector Memory CD8+ T Cells in a Subset of Clinically Stable Kidney Transplant Recipients: A Potential Marker for Late Graft Dysfunction. J Am Soc Nephrol, 25(8): 1856-68.


• 23. Molinié F, Vanier A, Woronoff AS, Guizard AV, Delafosse P, Velten M, Daubisse-Marillac L, Arveux P, Tretarre B (2014) Trends in breast cancer incidence and mortality in France 1990–2008. Breast Cancer Research Treatment, 147(1): 167-75.


• 24. Chaigne B, Dartigeas C, Benboubker L, Chaumier F, Ertault M, Lissandre S, Stacoffe M, Maillot F, Blasco H, Vourc'h P, Colombat P, Gyan E (2014) Could a citrus keep the haematologist away?. Br J Haematol, 166(2): 298-300.


• 25. Feddag ML, Blanchin M, Hardouin JB, Sébille V (2014) Power analysis on the time effect for the longitudinal Rasch model. Journal of Applied Measurement, 15(3): 292-301.


• 26. Goffinet N, Lecadet N, Cousin M, Peron C, Hardouin JB, Batard E, Montassier E (2014) Increasing use of 3rd-generation cephalosporins for pneumonia in the Emergency Department : may some prescriptions be avoided ?. European Journal of Clinical Microbiology & Infectious Diseases, 33(7): 1095-1099.


• 27. Combescure C, Foucher Y, Jackson D (2014) Meta-analysis of single-arm survival studies: a distribution-free approach for estimating summary survival curves with random effects. Statistics in Medicine, 33(15): 2521-37.


• 28. Lorent M, Giral M, Foucher Y (2014) Net time-dependent ROC curves: a solution for evaluating the accuracy of a marker to predict disease-related mortality. Statistics in Medicine, 33(14): 2379-89.


• 29. Sébille V, Blanchin M, Guillemin F, Falissard B, Hardouin JB (2014) A simple ratio-based approach for power and sample size determination for Rasch analysis. BMC Medical Research Methodology, 14(1): 87.


• 30. Roulet L, Ballereau F, Hardouin JB, Chiffoleau E, Potel G, Asseray N (2014) Adverse Drug Event Non-Recognition in Emergency Departments: An Exploratory Study on Factors Related to Patients and Drugs. Journal of Emergency Medicine, 46(6): 857-864.


• 31. Challet G, Hardouin JB, Boutin C, Gorwood P, Le Bourvellec JD, Feuillet F, Vénisse JL, Grall-Bronnec M (2014) A shorter and multidimensional version of the Gambling Attitudes and Beliefs and Survey (GABS-23). Journal of Gambling Studies , 30(2): 349-367.


• 32. Cinotti R, Dordonnat-Moynard A, Feuillet F, Roquilly A, Rondeau N, Lepelletier D, Caillon J, Asseray N, Blanloeil Y, Rozec B, Asehnoune K (2014) Risk factors and pathogens involved in early ventilator-acquired pneumonia in patients with severe subarachnoid hemorrhage. Eur J Clin Microbiol Infect Dis, 33(5): 823-30.


• 33. Guillou-Landreat M, Sébille V, Victorri-Vigneau C, Foucher Y, Vénisse JL, Jolliet P (2014) Buprenorphine prescription compliance: an original observational and longitudinal study. Journal of Psychoactive Drugs, 46(2): 162-7.


• 34. Etcheverrigaray F, Grall-Bronnec M, Blanchet MC, Jolliet P, Victorri-Vigneau C (2014) Ibuprofen dependence: a case report. Pharmacopsychiatry, 47(3): 115-117.


• 35. Cholet J, Sauvaget A, Vanelle J, Hommet C, Mondon K, Mamet J, Cano A (2014) Using the Brief Assessment of Cognition in Schizophrenia (BACS) to assess cognitive impairment in older patients with schizophrenia and bipolar disorder . Bipolar disorders, 16(3): 326-336.


• 36. Rat C, Quéreux G, Monnier A, Gautier J, Bonnaud-Antignac A, Khammari A, Dréno B, N'guyen S, Monegier du Sorbier M , Gaultier A (2014) Patients at elevated risk of melanoma: Individual predictors of non-compliance to GP referral for a dermatologist consultation. Preventive Medicine, 64: 48-53.


• 37. Rouquette A, Blanchin M, Sébille V, Guillemin F, Côté SM, Falissard B, Hardouin JB (2014) Determination of the Minimal Clinically Important Difference using Item Response Theory Models: an attempt to solve the issue of the association with baseline score. Journal of Clinical Epidemiology, 64(4): 433-440.


• 38. Montassier E, Batard E, Massart S, Gastinne T, Carton T, Caillon J, Le Fresne S, Caroff N, Hardouin JB, Moreau P, Potel G, Le Vacon F, De La Cochetière MF (2014) 16S rRNA Gene Pyrosequencing Reveals Shift in Patient Faecal Microbiota During High-Dose Chemotherapy as Conditioning Regimen for Bone Marrow Transplantation.. Microbial Ecology, 67(3): 690-699.


• 39. Dantan E, Combescure C, Lorent M, Ashton-Chess J, Daguin P, Classe JM, Giral M, Foucher Y (2014) An original approach was used to better evaluate the capacity of a prognostic marker using published survival curves. Journal of Clinical Epidemiology, 67(4): 441-8.


• 40. Roquilly A, Seguin P, Mimoz O, Feuillet F, Rosenczvei E, Chevalier F, Loutrel O, Mallédant Y, Sébille V, Asehnoune K (2014) Risk factors for prolonged duration of mechanical ventilation in acute traumatic tetraplegic patients-a retrospective cohort study. J Crit Care, 29(2): 313.e7-13.


• 41. Le Maguet P, Roquilly A, Lasocki S, Asehnoune K, Carise E, Saint Martin M, Mimoz O, Le Gac G, Somme D, Cattenoz C, Feuillet F, Mallédant Y, Seguin P (2014) Prevalence and impact of frailty on mortality in elderly ICU patients: a prospective, multicenter, observational study. Intensive Care Med: published online.


• 42. Gaboriau L, Victorri-Vigneau C, Gérardin M, Allain-Veyrac G, Jolliet P, Grall-Bronnec M (2014) Aripiprazole : a new risk factor for pathological gambling ? A report of 8 cases report. Addict Behav, 39(3): 562-5.


• 43. Anthoine E, Coutherut J, Delmas C, Moret L (2014) Development and psychometric testing of a scale assessing the sharing of medical information and interprofessional communication: the CSI scale. BMC Health Service Research, 13: 14:126.


• 44. Senage T, Février D, Michel M, Pichot E, Duveau D, Tsui S, Trochu JN, Roussel J (2014) A mock circulatory system to assess the performance of continuous-flow left ventricular assist devices (LVADs): does axial flow unload better than centrifugal LVAD?. ASAIO J, 60(2): 140-7.


• 45. Foucher Y, Akl A, Rousseau V, Trébern-Launay K, Lorent M, Kessler M, Ladrière M, Legendre C, Kreiss H, Rostaing L, Kamar N, Mourad G, Garrigue V, Morelon E, Daurès JP, Soulillou JP, Giral M (2014) An alternative approach to estimate age-related mortality of kidney transplant recipients compared to the general population: results in favor of old-to-old transplantations. Transplant International, 27(2): 219-25.


• 46. Boyer L, Baumstarck K, Michel P, Boucekine M, Anota A, Bonnetain F, Coste J, Falissard B, Guilleux A, Hardouin JB, Loundou A, Mercier M, Mesbah M, Rouquette A, Sébille V, Verdam M, Ghattas B, Guillemin F, Auquier P (2014) Statistical challenges in quality of life and cancer: New avenues for future researches. Expert Review of Pharmacoeconomics & Outcomes Research, 14(1): 19-22.


• 47. Guilleux A, Blanchin M, Hardouin JB, Sébille V (2014) Power and sample size determination in the Rasch model: Evaluation of the robustness of a numerical method to non-normality of the latent trait. Plos One, 9(1): e0083652.


• 48. Lucas JP, Bellanger L, Le Strat Y, Le Tertre A, Glorennec P, Le Bot B, Etchevers A, Mandin C, Sébille V (2014) Source Contribution of Lead in Residential Floor Dust and Within-Home Variability of Dust Lead Loading. Science of the Total Environment, 70(127): 768-779.


• 49. Combescure C, Perneger T, Weber D, Daurès JP, Foucher Y (2014) Prognostic ROC Curves: A Method for Representing the Overall Discriminative Capacity of Binary Markers with Right-Censored Time-to-Event Endpoints. Epidemiology, 25(1): 103-9.


• 50. Tessier P, Sultan-Taïeb H., Barnay T. (2014) Worker replacement and cost-benefit analysis of life-saving health care programs, a precautionary note . Health Economics, Policy and Law, 9(2): 215-29.


• 51. Darnis D, Allain-Veyrac G, Jolliet P (2014) The special case of diclofenac. Enliven Archive : .


• 52. Bouquié R, Deslandes G, Nieto-Bernaldez B, Renaud C, Dailly E, Jolliet P (2014) A fast LC-MS/MS assay for methotrexate monitoring in plasma: validation, comparison to FPIA and application in the setting of carboxypeptidase therapy . Anal Methods , 6: 178-186.


• 53. Allavena C, Dailly E, Reliquet V, Bonnet B, Pineau S, Andre-Garnier E, Boutoille D, Bouquié R, Raveleau A, Bouchez S, Billaud E, Raffi F (2014) Switching from Tenofovir/Emtricitabine and Nevirapine to Tenofovir/Emtricitabine/Rilpivirine Single Tablet Regimen in Virologically Suppressed, HIV-1 Infected Subjects . J Antimicrob Chemother, 69: 2804-2808.


• 54. Dailly E, Allavena C, Deslandes G, Bouquié R, Jolliet P, Raffi F (2014) Clinical relevance of the interaction when switching non-nucleoside reverse transcriptase inhibitors in patients infected with HIV . Curr Clin Pharmacol., 9: 399-403.


• 55. Victorri-Vigneau C, Gérardin M, Rousselet M, Guerlais M, Grall-Bronnec M, Jolliet P (2014) An update on zolpidem abuse and dependence . J Addict Dis. , 33: 15-23.


• 56. Bouquié R, Wainstein L, Pilet P, Mussini J, Deslandes G, Clouet J, Dailly E, Jolliet P, Victorri-Vigneau C (2014) Crushed and injected buprenorphine tablets : characteristics of princeps and generic solutions. Plos One, 9: e113991.


• 57. Victorri-Vigneau C, Collin C, Messina-Gourlot M, Raffournier C, Mallaret M, Besse J, Courné MA, Richard N, Sébille V, Arnaud P, participants of expert group of the study (2014) Designing a tool allowing for a standardized assessment of resistance to drug diversion. Expert Opin Drug Deliv, 11(7): 995-1004.


• 58. Etcheverrigaray F, Cholet J, Sauvaget A, Guerlais M, Jolliet P, Grall-Bronnec M, Victorri-Vigneau C (2014) Thiocolchicoside and alcohol abstinence: a case report . Alcohol Alcohol, 49: 486-7.


• 59. Rat C, Penhouet G, Gaultier A, Chaslerie A, Pivette J, NGuyen JM, Victorri-Vigneau C (2014) Did the new French pay-for-performance system modify benzodiazepine prescribing practices? A description based on the prospective follow-up of two historical cohorts. BMC Health Serv Res, 14: 301.


• 60. Camus C, Sébille V, Legras A, Garo B, Renault A, Le Corre P, Donnio PY, Gacouin A, Perrotin D, Le Tulzo Y, Bellissant E (2014) Mupirocin/chlorexidine to prevent methicillin-resistant Staphylococcus aureus infections: post hoc analysis of a placebo-controlled, randomized trial using mupirocin/chlorhexidine and polymyxin/tobramycin for the prevention of acquired infections in intub. Infection, 42(3): 493-502.


• 61. Schwartz C, Sajobi T, Verdam M, Sébille V, Lix L, Guilleux A, Sprangers M (2014) Method variation in the impact of missing data on response shift detection. Quality of Life Research : .


• 62. Audrain M, Thomas C, Mirallie S, Bourgeois N, Sébille V, Rabetrano H, Durand-Zaleski I, Boisson R, Persyn M, Pierres C, Mahlaoui N, Fischer A (2014) Evaluation of the T-cell receptor excision circle assay performances for severe combined immunodeficiency neonatal screening on Guthrie cards in a French single centre study. Clinical Immunology, 150(2): 137-139.


• 63. Gregoire M, Deslandes G, Renaud C, Bouquié R, Allavena C, Raffi F, Jolliet P, Dailly E (2014) A liquid chromatography-tandem mass spectrometry assay for quantification of rilpivirine and dolutegravir in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci, 971: 1-9.


• 64. Couvrat-Desvergnes G, Masseau A, Benveniste O, Bruel A, Hervier B, Mussini J, Buob D, Hachulla E, Rémy P, Azar R, Namara E, Macgregor B, Daniel L, Lacraz A, Broucker T, Rouvier P, Carli P, Laville M, Dantan E, Hamidou M, Moreau A., Fakhouri F. (2014) The spectrum of renal involvement in patients with inflammatory myopathies. Medicine, 93(1): 33-41.


• 65. Lelorain S, Brédart A, Dolbeault S, Cano A, Bonnaud-Antignac A, Cousson-Gélie F, Sultan S (2014) How can we explain physician accuracy in assessing patient distress? A multilevel analysis in patients with advanced cancer. Patient Education and Counseling, 94(3): 322-327.


• 66. Cinotti R, Roquilly A, Mahé PJ, Feuillet F, Yehia A, Belliard G, Lejus C, Blanloeil Y, Teboul JL, Asehnoune K (2014) Pulse pressure variations to guide fluid therapy in donors: A multicentric echocardiographic observational study. Journal of Critical Care: published online.

Chapitres d'ouvrage

• 1. Guerlais M, Victorri-Vigneau C, Jolliet P (2014) Mécanismes de l’addiction : particularité des adolescents. In Dans PICHEROT G., STHENEUR C. Addiction chez l’enfant et l’adolescent, collection Progrès en pédiatrie, Editions Douin. (): 0.


• 2. Sauvaget A, Victorri-Vigneau C (2014) Prescription et surveillance des psychotropes : prescrire et surveiller un médicament appartenant aux principales classes de psychotropes. . In Dans Psychiatrie, collection Référence ECN, Editions Estem de Boeck. (): 0.


• 3. Cholet J, Victorri-Vigneau C (2014) Addiction aux médicaments psychotropes (benzodiazépines et apparentés) : repérer, diagnostiquer, évaluer le retentissement d’une addiction aux médicaments psychotropes (benzodiazépines et apparentés) ; Indications et principes du sevrage thérapeutique, ar. In Dans Psychiatrie, collection Référence ECN, Editions Estem de Boeck. (): 0.


• 4. Robert C, Victorri-Vigneau C, Sauvaget A (2014) Douleur en santé mentale : repérer, prévenir, et traiter les manifestations douloureuses chez le patient psychiatrique et la personne atteinte de troubles envahissant du développement ; connaître les bases en psychopathologie de la douleur aiguë et chroni. In Dans Psychiatrie, collection Référence ECN, Editions Estem de Boeck. (): 0.


• 5. Ghosn J, Bouquié R, Viard J, Potel G (2014) Principales classes d’antibiotiques , d’antiviraux, d’antifongiques et d’antiparasitaires Prescription et surveillance. . In Dans Le bon usage du médicament et des thérapeutiques non médicamenteuses ; collection des enseignants Editions Med-line (): 0.

Articles dans une revue nationale

• 1. Reignier A, Sacchetto E, Hardouin JB, Orsonneau J, Le Carrer D, Delaroche O, Bigot-Corbel E (2014) Evaluation d’une méthode de dosage direct du LDL-cholestérol et son impact en terme de prise en charge thérapeutique. Annales de Biologie Clinique, 72(5): 593-598.


• 2. Gillaizeau F, Giral M, Dantan E, Dragun D, Soulillou JP, Foucher Y (2014) Multi-state analysis of kidney transplant recipients outcome: a semi-Markov model for studying the role of pre-transplant sensitization against Angiotensin II Type 1 receptor. Journal de la Société Française de Statistique , 155(1): 117-133.


• 3. Caillon J, Challet G, Grall-Bronnec M, Allain-Veyrac G, Jolliet P, Grall-Bronnec M (2014) Jeux vidéo : les motivations et l'intensité de la pratique évoluent-elles avec l'âge ? Comparaison entre une population de joueurs adolescents et adultes. Arch Pediatr, 21(3): 251-257.


• 4. Cheron-Blumel A, Grall-Bronnec M, Victorri-Vigneau C, Péron E, Betaud C, Jolliet P, Amar M (2014) Prescription of methylphenidate for children : importance of recommendations to limit misuse. Arch Pediatr, 21: 852-9.


• 5. Gregoire M, Boutoleau-Bretonnière C, Deslandes G, Monteil-Ganière C, Bouquié R, Dailly E, Renaud C, Azoulay C, Pineau A, Grison-Hernando H, Jolliet P (2014) Early lactic acidosis following massive acetaminophen poisoning: a metabolic disorder sometimes unknown [L’acidose lactique précoce lors de l’intoxication massive au paracetamol: un trouble métabolique parfois méconnu] . Toxicologie Analytique et Clinique : sous presse.


• 6. Deslandes G, Bouquié R, Boels D, Gregoire M, Grison-Hernando H, Azoulay C, Pineau A, Monteil-Ganière C, Renaud C, Dailly E, Harry P, Jolliet P (2014) Accidental poisoning with brimonidine eye drops in a 9-day-old infant . Toxicologie Analytique et Clinique : sous presse.


• 7. Petit A, Bonnaud-Antignac A, Roquelaure Y (2014) Cancer et parcours professionnel. Psycho-Oncologie, 8: 151-152.

2013

Articles dans une revue internationale

• 1. de Bock E, Hardouin JB, Blanchin M, Le Neel T, Kubis G, Dantan E, Bonnaud-Antignac A, Sébille V (2013) Rasch-family models are more valuable than score-based approaches for analysing longitudinal PRO with intermittent missing data. Statistical Methods in Medical Research : Published online.


• 2. Challet G, Grall-Bronnec M, Quistrebert-Davanne V, Hardouin JB, Vénisse JL (2013) Texas Hold’em Poker: a qualitative analysis of gamblers’ perceptions. Journal of Gambling Issues, 28: 1-28.


• 3. Chapal M, Néel M, Le Borgne F, Meffray E, Carceles O, Hourmant M, Giral M, Foucher Y, Moreau A, Fakhouri F (2013) Increased soluble flt-1 correlates with delayed graft function and early loss of peritubular capillaries in the kidney graft. Transplantation, 96(8): 739-44.


• 4. Moret L, Anthoine E, Aubert- Wastiaux H, Le Rhun M, Leux C, Mazereeuw-Hautier J, Stalder J, Barbarot S (2013) TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents.. PLoS One, 8(10): e76493.


• 5. Clermidi P, Podevin G, Crétolle C, Sarnacki S, Hardouin JB (2013) The challenge of measuring quality of life for children with Hirschsprung's diseases or anorectal malformations. Journal of Pediatric Surgery, 48(10): 2118-2127.


• 6. Blanchard C, Mathonnet M, Sebag F, Caillard C, Hamy A, Volteau C, Heymann MF, Wyart V, Drui D, Roy M, Cariou Y, Archambaud F, Rodien P, Henry JF, zarnegar R, Hardouin JB, Mirallié E (2013) Surgery for 'asymptomatic' mild primary hyperparathyroidism improves some clinical symptoms postoperatively. European Journal of Endocrinology, 169(5): 665-672.


• 7. Giral M, Foucher Y, Dufay A, Duong Van Huyen J, Renaudin K, Moreau A, Philippe A, Hegner B, Dechend R, Brouard S, Cesbron A, Castagnet S, Devys A, Soulillou JP, Dragun D (2013) Pretransplant Sensitization Against Angiotensin II Type 1 Receptor Is a Risk Factor for Acute Rejection and Graft Loss. American Journal of Transplantation, 13(10): 2567-76.


• 8. Jean M, Tessier P, Bonnaud-Antignac A, Fréour T, Barriere P, Dabouis G (2013) Is the debate about single or double embryo transfer following in vitro fertilisation really an ethical dilemma?. Clinical Ethics, 8(2): 61-69.


• 9. Lucas JP, Sébille V, Le Tertre A, Le Strat Y, Bellanger L (2013) Multilevel modelling on survey data: impact of the 2-level weights used in the pseudolikelihood. Journal of Applied Statistics: published online.


• 10. Roquilly A, Cinotti R, Jaber S, Vourc’h M, Pengam F, Mahé PJ, Lakhal K, Demeure Dit Latte D, Rondeau N, Loutrel O, Paulus J, Rozec B, Blanloeil Y, Vibet MA, Sébille V, Feuillet F, Asehnoune K (2013) Implementation of an evidence-based extubation readiness bundle in 499 brain-injured patients - a before-after evaluation of a quality improvement project. American Journal of Respiratory and Critical Care Medicine, 188(8): 958-966.


• 11. Victorri-Vigneau C, Feuillet F, Wainstein L, Grall-Bronnec M, Pivette J, Chaslerie A, Sébille V, Jolliet P (2013) Pharmacoepidemiological characterisation of zolpidem and zopiclone usage. Eur J Clin Pharmacol, 69(11): 1965-1972.


• 12. Vanier A, Leux C, Allioux C, Billon-Delacourt S, Lombrail P, Molinié F (2013) Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France). Cancer Epidemiology, 37(5): 683-87.


• 13. Trébern-Launay K, Giral M, Dantal J, Foucher Y (2013) Comparison of the risk factors effects between two populations: two alternative approaches illustrated by the analysis of first and second kidney transplant recipients. BMC Medical Research Methodology, 13: 102.


• 14. Pottier P, Dejoie T, Hardouin JB, Le Loupps AG, Castillo J, Planchon B, Bonnaud-Antignac A, Leblanc V (2013) Effect of stress on clinical reasoning during simulated ambulatory consultations. Medical teacher, 35(6): 472-480.


• 15. Le Rhun A, Gagnayre R, Moret L, Lombrail P (2013) Analysis of perceived stress by hospital caregivers in the practice of therapeutic education: implications for supervision. Glob Health Promot., 20(2): 43-47.


• 16. Cantarovich D, Hodemon-Corne B, Trébern-Launay K, Giral M, Foucher Y, Dantan E (2013) Early steroid withdrawal compared with steroid avoidance correlates with graft failure among kidney transplant recipients with an history of diabetes. Transplantation Procedings, 45(4): 1497-502.


• 17. El Arid J, Senage T, Toquet C, Al Habash O, Mugniot A, Baron O, Roussel J (2013) Human comparative experimental study of surgical treatment of atrial fibrillation by epicardial techniques.. J Cardiothorac Surg, 31(8): 140.


• 18. Mantoo S, Meurette G, Wyart V, Hardouin JB, Crétolle C, Capito C, Sarnacki S, Podevin G, Lehur PA (2013) The impact of anorectal malformations on anorectal function and social integration in adulthood: report from a national database. Colorectal Disease, 15(6): e330-e335.


• 19. Batard E, Ollivier F, Boutoille D, Hardouin JB, Montassier E, Caillon J, Ballereau F (2013) Relationship between hospital antibiotic use and quinolone resistance in Escherichia coli . International Journal of Infectious Diseases, 17(4): e254-e258.


• 20. Danger R, Paul C, Giral M, Foucher Y, Degauque N, Pallier A, Durand M, Castagnet S, Duong Van Huyen J, Delahousse M, Renaudin K, Soulillou JP, Brouard S (2013) Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection. PLoS One, 8(4): e60702.


• 21. Oulhote Y, Le Tertre A, Etchevers A, Le Bot B, Lucas JP, Mandin C, Le Strat Y, Lanphear B, Glorennec P (2013) Implications of different residential lead standards on children’s blood lead levels in France: Predictions based on a national cross-sectional survey. Int. J. Hyg. Environ. Health, 216: 743-750.


• 22. Roquilly A, Perbet S, Simonneau F, Cinotti R, Sébille V, Volteau C, Gratas C, Minet-Quinard R, Loutrel O, Rozec B, Lejus C, Constantin JM, Asehnoune K (2013) Ammonia plasma concentration and prolonged infusion of remifentanil in patients with acute kidney injury. Minerva Anestesiol: .


• 23. Gross R, Leboeuf F, Hardouin JB, Lempereur M, Perrouin-Verbe B, Remy-Neris O, Brochard S (2013) The influence of gait speed on co-activation in unilateral spastic cerebral palsy children. Clinical Biomechanics, 28(3): 312–317.


• 24. Goineau A, Marchand V, Rigaud J, Bourdin S, Rio E, Campion L, Bonnaud-Antignac A, Mahé MA, Supiot S (2013) Prospective evaluation of quality of life 54 months after high-dose intensity-modulated radiotherapy for localized prostate cancer. Radiation Oncoogy, 8(53): 1-7.


• 25. Blanchin M, Hardouin JB, Guillemin F, Falissard B, Sébille V (2013) Power and sample size determination for the group comparison of patient-reported outcomes with Rasch family models. PLoS ONE, 8(2): e57279.


• 26. Le Bras M, Roquilly A, Deckert V, Langhi C, Feuillet F, Sébille V, Mahé PJ, Bach K, Masson D, Lagrost L, Costet P, Asehnoune K, Cariou B (2013) Plasma PCSK9 Is a Late Biomarker of Severity in Patients With Severe Trauma Injury. J Clin Endocrin Metab, 98(4): E732-736.


• 27. Roulet L, Ballereau F, Hardouin JB, Chiffoleau A, Moret L, Potel G, Asseray N (2013) Assessment of adverse drug event recognition by emergency physicians in a French teaching hospital. Emergency Medicine Journal, 30(1): 63-67.


• 28. Bellanger L, Victorri-Vigneau C, Pivette J, Jolliet P, Sébille V (2013) Discrimination of psychotropic drugs over-consumers using a threshold exceedance based approach. Statistical Analysis and Data-Mining, 6(2): 91-101.


• 29. Clément R, Gérardin M, Victorri-Vigneau C, Guigand G, Wainstein L, Jolliet P (2013) Medical, social and law characteristics of intoxicant's users medically examined in police custody. J Forensic Leg Med, 20: 1083-6.


• 30. Dailly E, Arnould J, Fraissinet F, Naux E, Letard de la Bouralière M, Bouquié R, Deslandes G, Jolliet P, Le Floch R (2013) Pharmacokinetics of ertapenem in burns patients. Int J Antimicrob Agents, 42: 48-52.


• 31. Dailly E, Fraissinet F, Deslandes G, Bouquié R, Jolliet P (2013) Evaluation of the QMS® Teicoplanin Immunoassay (ThermoFisher Scientific) on Cobas® 8000 System (Roche Diagnostics) and comparison to fluorescence polarization immunoassay for the determination of Teicoplanin concentrations in human plasma . J Clin Lab Anal, 27: 96-8.


• 32. Dailly E, Allavena C, Bouquié R, Deslandes G, Raffi F, Jolliet P (2013) Effect of efavirenz, nevirapine, etravirine, raltegravir administration on the pharmacokinetics of ritonavir-boosted darunavir in a population of HIV-infected Patients. AIDS Research and Human Retroviruses , 29(29): 42-46.


• 33. Bouquié R, Deslandes G, Renaud C, Dailly E, Jolliet P (2013) Validation and application of a fast semi-automated whole blood extraction for LC-MS/MS simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus - Application to high throughput routine therapeutic drug monitoring. . Anal Methods , 5: 5079-5088.


• 34. Peuvrel L, Chiffoleau A, Quéreux G, Brochard A, Saint-Jean M, Batz A, Jolliet P, Dréno B (2013) Melanoma and Rituximab: an incidental association?. Dermatology, 226(3): 275-8.


• 35. Mahé J, Meurette A, Moreau A, Vercel C, Jolliet P (2013) Renal thrombotic microangiopathy caused by interferon beta-Ia treatment for multiple sclerosis. Drug Design, Development and Therapy , 7: 723-8.


• 36. Bobin-Dubigeon C, Biron C, Volteau C, Piroth L, Biron A, Perré P, Leport C, Prazuck T, Sébille V, Raffi F, Bard J (2013) Short communication: Paraoxonase 1 (PON1) in French HIV-infected patients under antiretroviral therapy: relationship with the metabolic syndrome and inflammation. AIDS Research and Human Retroviruses, 29(12): 1571-1574.


• 37. Orsonneau J, Fraissinet F, Sébille V, Dudouet D, Bigot-Corbel E (2013) Suitability of POC lactate methods for fetal and perinatal lactate testing: considerations for accuracy, specificity and decision making criteria. Clinical Chemistry and Laboratory Medicine, 51(2): 397-404.


• 38. Gillet N, Fouquereau E, Bonnaud-Antignac A, Mokounkolo R, Colombat P (2013) The mediating role of organizational justice in the relationship between transformational leadership and nurses' quality of work life: A cross-sectional questionnaire survey. International Journal of Nursing Studies, 50: 1359-1367.

Chapitres d'ouvrage

• 1. Durand G, Tessier P, Dabouis G (2013) La Consultation d’Ethique Clinique : le principisme en action. In L'éthique clinique et les normes, Guillaume Durand et Jean-Marie Lardic (dir.), Editions Nouvelles Cécile Defaut (): 0.

Articles dans une revue nationale

• 1. Lapeyre-Mestre M, Sapede C, Moore N, participants of round table n°5 of Giens workshops XXVIIIth: P. BILBAULT, P. BLIN, D. CHOPY, D. EVANS, F. GUEYFFIER, L. LACOIN, M. MALBEZIN, J. MICALLEF, D. MORLET-VIGIER, S. MULLER, E. OGER, Y. PLETAN, G. PONS, P. VERPILLAT and C. VIGNEAU (2013) Pharmacoepidemiology studies: what levels of evidence and how can they be reached?. Thérapie, 68(4): 241-52.


• 2. Moret L, Anthoine E, Gillet N, Fouquereau E, Colombat P (2013) Organisation du travail, démarche participative et satisfaction des patients hospitalisés : une évaluation dans 47 services d’oncohématologie. Psycho-Oncol, 8(3): 157-164.


• 3. Arimone Y, Bidault I, Dutertre JP, Gérardin M, Guy C, Haramburu F, Hillaire-Buys D, Meglio C, Penfornis C, Théophile H, Valnet-Rabier MB (2013) Updating the French method for the causality assessment of adverse drug reactions. Thérapie, 68(2): 69-76.


• 4. Ruellan AL, Bellissant E, Bourgeois H, Carlhant-Kowalski D, Douillard JY, Jamet A, Jolliet P, Lainé-Cessac P, Metges JP, Polard-Riou E, Riche C, Grude F (2013) Collaboration entre l'Observatoire dédié au cancer et les Centre régionaux de pharmacovigilance : premiers résultats sur la pharmacovigilance des médicaments anticancéreux. La Lettre du Pharmacologue, 27(2): 51-7.


• 5. Guillou-Landreat M, Victorri-Vigneau C, Grall-Bronnec M, Sébille V, Vénisse JL, Jolliet P (2013) Impact des politiques de santé publiques sur les consultations en addictologie à partir d’un suivi longitudinal de 1998 à 2007. Ann Med Psychol , 171(6): 367-371.


• 6. Dailly E, Papuchon E, Deslandes G, Bouquié R, Jolliet P, Cantarovich D (2013) Modified mycophenolic acid pharmacokinetics after replacement of tacrolimus by sirolimus following simultaneous pancreas/kidney transplantation. Journal of Applied Biopharmaceutics and Pharmacokinetics , 1: 1-4.


• 7. Chassevent-Pajot A, Grall-Bronnec M (2013) Alcool et adolescence. La Lettre du psychiatre, 9(2): 14-19.


• 8. Lagadec M, Poudat FX, Grall-Bronnec M (2013) Quand le sexe devient envahissant : à propos d'un cas d'addict sexuel. Sexualités humaines, 18: 42-50.


• 9. Ameur-Henni A, bideau C, Routon X, Cholet J (2013) Prévalence et enjeux du dépistage de la consommation d'alcool chez les personnes âgées hospitalisées en court séjour gériatrique . Gériatrie, Psychologie et Neuropsychiatrie du Vieillissement , 11(1): 33-41.

Thèses/Rapports/Mémoires

• 1. Foucher Y (2013) Modélisation et pronostic de l'évolution de pathologies chroniques : Applications en transplantation renale. , 193.

2012

Articles dans une revue internationale

• 1. Terrien N, Anthoine E, Moret L (2012) Development and validation of a scale aiming at measuring perceived patient-centered care by professionals. Geriatr Psychol Neuropsychiatr Vieil, 10(4): 403-411.


• 2. Brouard S, Pallier A, Renaudin K, Foucher Y, Danger R, Devys A, Cesbron A, Guillot-Gueguen C, Ashton-Chess J, Le Roux S, Harb J, Roussey G, Subra JF, Villemain F, Legendre C, Bemelman FJ, Orlando G, Garnier A, Jambon H, Le Monies De Sagazan H, Braun L, Noel C, Pillebout E, Moal MC, Cantarell C, Hoitsma A, Ranbant M, Testa A, Soulillou JP, Giral M (2012) The Natural History of Clinical Operational Tolerance After Kidney Transplantation Through Twenty-Seven Cases. Am J Transplant, 12(12): 3296-307.


• 3. Hardouin JB, Audureau E, Leplège A, Coste J (2012) Spatio-temporal Rasch analysis of Quality of life outcomes in the french general population. Measurement invariance and group comparisons . BMC Medical Research Methodology, 12: 182.


• 4. Danger R, Foucher Y (2012) Time dependent ROC curves for the estimation of true prognostic capacity of microarray data. Statistical Applications in Genetics and Molecular Biology, 11(6): Article 1.


• 5. Combescure C, Daurès JP, Foucher Y (2012) A literature-based approach to evaluate the predictive capacity of a marker using time-dependent summary receiver operating characteristics. Stat Methods Med Res: online first.


• 6. Moret L, Lefort C, Terrien N (2012) How to write, how to implement and how to evaluate a practice guideline in order to improve quality of care?. Transfus Clin Biol, 19(4): 174-177.


• 7. Grall-Bronnec M, Challet G, Sébille V, Gorwood P, Boutin C, Vénisse JL, Hardouin JB (2012) A French adaptation of the Gambling Related Cognitions Scale (GRCS): A useful tool for assessment of irrational thoughts among gamblers. Journal of Gambling Issues, 27: 1-21.


• 8. Hamel JF, Hardouin JB, Le Neel T, Kubis G, Roquelaure Y, Sébille V (2012) Study of different methods for comparing groups by analysis of subjective health measurements. PLoS One, 7(10): e44695.


• 9. Trébern-Launay K, Foucher Y, Giral M, Legendre C, Kreiss H, Kessler M, Ladrière M, Kamar N, Rostaing L, Garrigue V, Mourad G, Morelon E, Soulillou JP, Dantal J (2012) Poor long-term outcome in second kidney transplantation : a delayed event. PLoS One, 7(10): e47915.


• 10. Feddag ML (2012) Pairwise marginal likelihood for the Bradley-Terry model. Statistical Theory and Practise : (under press).


• 11. Thibaud A, Foucher Y, Danger R, Migone T, Pallier A, Castelli C, Castagnet S, Devys A, Cesbron A, Giral M, Soulillou JP, Brouard S (2012) BAFF and BAFF-R levels are associated with risk of long-term kidney graft dysfunction and development of donor-specific antibodies. Am J Transplant, 12(10): 2754-62.


• 12. Decaux O, Renault A, Sébille V, Moreau P, Attal M, Voillat L, Pegourie B, Tiab M, Facon T, Zerbib R, Grosbois B, Bellissant E, Intergroupe Francophone du Myélome (2012) Predictive factors of survival after thalidomide therapy in advanced multiple myeloma: long-term follow-up of a prospective multicenter nonrandomized phase II study in 120 patients. Clin Lymphoma Myeloma Leuk, 12(6): 418-22.


• 13. Michel L, Foucher Y, Vukusic S, Confavreux C, De Seze J, Brassat D, Clanet M, Clavelou P, Ouallet J, Brochet B, Pelletier J, Lebrun C, Lepage E, Le Frere F, Le Fresne S, Jacq M, Barriere P, Wiertlewski S, Laplaud D (2012) Increased risk of multiple sclerosis relapse after in vitro fertilisation. Neurol Neurosurg Psychiatry, 83(8): 796-802.


• 14. Dailly E, Rodallec A, Allavena C, Deslandes G, Garnier E, Billaud E, Ferré V, Reliquet V, Bouquié R, Raffi F, Jolliet P (2012) Virological response to darunavir in patients infected with HIV is linked to darunavir resistance–associated mutations corrected by the count of mutations with positive impact and is not associated with pharmacological and combined virological/pharmacolog. Fundamental and Clinical Pharmacology, 26(4): 538-542.


• 15. Feddag ML (2012) Generalized Estimating Equations to binary probit model. Communications in Statistics: Theory and Methods: (under press).


• 16. Feddag ML (2012) Pairwise likelihood estimation for the normal ogive model with binary data. Advances in Statistical Analysis : (under press).


• 17. Feddag ML (2012) Composite Marginal Likelihoods to the normal Bradley-Terry model. Communications in Statistics: Simulation and Computation , 41(3): 279-286.


• 18. Dailly E, Rodallec A, Allavena C, Deslandes G, Garnier E, Billaud E, Ferré V, Reliquet V, Bouquié R, Raffi F, Jolliet P (2012) Virogical response to darunavir in patients infected with HIV is linked to darunavir resistance-associated mutations corrected by the count of mutations with positive impact and is not associated with pharmacovigical and combined virogical/pharmacological. Fundamental&clinical pharmacology, 26(4): 538-542.


• 19. Bonnaud-Antignac A, Hardouin JB, Léger J, Dravet F, Sébille V (2012) Quality of life and coping of women treated for breast cancer and their caregivers. What are the interactions?. Journal of Clinical Psychology in Medical Settings, 19: 320-328.


• 20. Grall-Bronnec M, Wainstein L, Feuillet F, Challet G, Rocher B, Vénisse JL, Sébille V (2012) Clinical profiles as a function of level and type of impulsivity in a sample group of at-risk and pathological gamblers seeking treatment. J Gambl Stud, 28(2): 239-252.


• 21. Hardouin JB, Amri S, Feddag ML, Sébille V (2012) Towards Power And Sample Size Calculations For Item Response Theory Analysis For The Comparison Of Two Groups Of Patients. Statistics in Medicine, 31(11): 1277-1290.


• 22. Tessier P, Lelorain S, Bonnaud-Antignac A (2012) A comparison of the clinical determinants of health-related quality of life and subjective well-being in long term breast cancer survivors. European Journal of Cancer Care, 21(5): 692-700.


• 23. Foucher Y, Combescure C, Ashton-Chess J, Giral M (2012) Prognostic Markers: Data Misinterpretation Often Leads to Overoptimistic Conclusions. Am J Transplant, 12(4): 1060-1.


• 24. Paillé C, Leux C, Guilé R, Abbey H, Lombrail P, Moret L (2012) Causes of inappropriate hospital days: development and validation of a French tool in rehabilitation centers. Int J Qual Health C, 24(2): 121-8.


• 25. Feddag ML, Hardouin JB, Sébille V (2012) Pairwise- and marginal-likelihood estimation for the mixed Rasch model with binary data . Journal of Statistical Computation and Simulation , 82(3): 419-430.


• 26. Moret L, Anthoine E, Paillé C, Tricaud-Vialle S, Giraud-Roufast A, Gerbaud L, Michel P, Lombrail P (2012) Relationship between inpatient satisfaction and nurse absenteeism: an exploratory study using WHO-PATH performance indicators in France. BMC Research Notes, 5: 83.


• 27. Bellanger L, Husi P (2012) Statistical Tool for Dating and interpreting archaeological contexts using pottery. Journal of Archaeology Science, 39(4): 777-790.


• 28. Montassier E, Batard E, Segard J, Hardouin JB, Martinage A, Le Conte P, Potel G (2012) Base excess is an accurate predictor of elevated lactate in Emergency Department septic patients. American Journal of Emergency Medicine, 30(1): 184-187.


• 29. Foucher Y, Giral M, Soulillou JP, Daurès JP (2012) Cut-off estimation and medical decision making based on a continuous prognostic factor : the prediction of kidney graft failure. Int J Biostat, 8(1): 1–13.


• 30. Lucas JP, Le Bot B, Glorennec P, Etchevers A, Bretin P, Douay F, Sébille V, Bellanger L, Mandin C (2012) Lead Contamination in French Children’s Homes and Environment. Environmental Research, 116: 58–65.


• 31. Joyau C, Allain-Veyrac G, Dixneuf V, Jolliet P (2012) Anti tumor necrosis factor alpha therapy and increased risk of de novo psoriasis; is it really a paradoxical side effect?. Clin Expert Rheumatol, 30: 700-6.


• 32. Quaglio G, Faccini M, Victorri-Vigneau C, Casari R, Mathewson S, LICATA M, Lugoboni F (2012) Megadose bromazepam and zolpidem dependence: two case reports of treatment with flumazenil and valproate. Subst Abus., 33(2): 195-8.


• 33. Asehnoune K, Mahé PJ, Seguin P, Jaber S, Jung B, Guitton C, Chatel-Josse N, Subileau A, Tellier AC, Masson F, Renard B, Mallédant Y, Lejus C, Volteau C, Sébille V, Roquilly A (2012) Etomidate increases susceptibility to pneumonia in trauma patients. Intensive Care Medicine, 38(10): 1673-1682.


• 34. Touzeau C, Gagne K, Sébille V, Herry P, Chevallier P, Folléa G, Devys A, Moreau P, Mothy M, Cesbron Gautier A (2012) . Investigation of the impact of HLA-DPB1 matching status in 10/10 HLA matched unrelated hematopoietic stem cell transplantation: results of a French single center study. Human Immunology , 73(7): 711-714.


• 35. Biron A, Bobin-Dubigeon C, Volteau C, Piroth L, Perré P, Leport C, Prazuck T, Jovelin T, Billard M, Sébille V, Bard J, Raffi F, Biron C (2012) Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy. AIDS Research and Human Retroviruses, 28(12): 1672-1678.


• 36. Dely C, Sellier P, Dozol A, Segouin C, Moret L, Lombrail P (2012) Preventable readmissions of "community-acquired pneumonia": Usefulness and reliability of an indicator of the quality of care of patients' care pathways.. Presse Med, 9(1): 51-7.


• 37. Hamel JF, Fouquet N, Ha c, Goldberg M, Roquelaure Y (2012) Average Attributable Risk: a reliable and unbiased estimator of risk attribution. Epidemiology, 23(4): 646-647.


• 38. Glorennec P, Lucas JP, Mandin C, Le Bot B (2012) French children's exposure to metals via ingestion of indoor dust, outdoor playground dust and soil: Contamination data. Environment International, 45: 129-134.

Chapitres d'ouvrage

• 1. Challet G (2012) Les particularités du jeu en ligne et autres pratiques apparentées (Chapitre 18). In Le jeu pathologique. Comprendre, prévenir, traiter. (M. Grall-Bronnec): Paris, Editions Masson.


• 2. Challet G, Grall-Bronnec M, Quistrebert-Davanne V, Vénisse JL (2012) Étude exploratoire sur les habiletés liées au poker Texas Hold’em.. In Les addictions sans drogue : prévenir et traiter. Un défi sociétal. ( J.L. Vénisse et M. Grall-Bronnec): Paris, Editions Masson.


• 3. Grall-Bronnec M, Wainstein L, Lagadec M, Poudat FX (2012) Approches groupales dans le traitement du jeu pathologique.es groupales dans le traitement du jeu pathologique.. In Les addictions sans drogue : prévenir et traiter. Un défi sociétal (J.L. Vénisse et M. Grall-Bronnec): Paris, Editions Masson.


• 4. Guillou-Landreat M, Grall-Bronnec M (2012) Les facteurs de risque socio-environnementaux. In Le jeu pathologique. Comprendre, prévenir, traiter. (M. Grall-Bronnec): Paris, Editions Masson.


• 5. Caillon J, Grall-Bronnec M (2012) Genre et âge. In Le jeu pathologique. Comprendre, prévenir, traiter. (M. Grall-Bronnec): Paris, Editions Masson.


• 6. Lagadec M, Grall-Bronnec M (2012) Vulnérabilité psychologique. In Le jeu pathologique. Comprendre, prévenir, traiter. (M. Grall-Bronnec): Paris, Editions Masson.


• 7. Grall-Bronnec M, Guillou-Landreat M (2012) Les comorbidités psychiatriques et addictives du jeu pathologique. In Le jeu pathologique. Comprendre, prévenir, traiter. (M. Grall-Bronnec): Paris, Editions Masson.


• 8. Bonnaud-Antignac A (2012) Bases de la psychologie. In UE7 Santé-Société-Humanité (): Masson.


• 9. Damase-Michel C, Jean-Pastor M, Jolliet P, Jonville-Bera AP, Lacroix I, Louvigne C, Parry E (2012) Chapitre 15 – Infectiologie : 15.1 Antibiotiques. . In « Médicaments et grossesse : prescrire et évaluer le risque » Annie-Pierre Jonville-Béra, Thierry Vial Edition Elsevier Masson (): 0.


• 10. Louvigne C, Jolliet P, Jonville-Bera AP (2012) Chapitre 20 – Pneumologie. In Participation à un livre : « Médicaments et grossesse : prescrire et évaluer le risque » Annie-Pierre Jonville-Béra, Thierry Vial Edition Elsevier Masson (): 0.


• 11. Bonnaud-Antignac A (2012) Ce que dit le plan cancer : le point de vue de la psycho-oncologue. In Les étapes du parkinson, l’annonce d’une maladie de parkinson. Guide pratique pour une annonce personnalisée (Laboratoire GSK): 0.


• 12. Bonnaud-Antignac A, Preau (2012) Adaptation et Oncologie. In Psychologie de la santé, Théories de l’adaptation (Elisabeth Spitz, Cyril Tarquinio): De Boeck.


• 13. Bourdon M, Gautier J, Rocher B, Challet G (2012) Etude des réactions anxieuses à la déconnexion d’un M.M.O.R.P.G.. In Les addictions sans drogue : prévenir et traiter. Un défi sociétal. (sous la direction de J.L. Vénisse et M. Grall-Bronnec): Paris, Editions Masson.

Articles dans une revue nationale

• 1. Molinié F, Vanier A, Tretarre B, Guizard AV, Arveux P, Poillot ML, Woronoff AS, Velten M, Binder-Foucard F, Daubisse-Marillac L, Delafosse P (2012) Incidence du cancer in situ et invasif du sein en France (1990-2008) – Données des registres de cancer (réseau FRANCIM). Bulletin Epidémiologique Hebdomadaire InVS - Numéro Thématique, 35-36-37: 395-98.


• 2. Acier D, Boudoukha A, Grall-Bronnec M, Romo L, Salomé F, Caillon J, Vénisse JL (2012) Interventions menées par Internet en addictologie. Bénéfices et limites : revue de la littérature. Alcoologie et Addictologie, 34(2): 113-119.


• 3. Guillou-Landreat M, Grall-Bronnec M, Vénisse JL (2012) Addictions comportementales. La Presse Médicale (special issue : Addictions), 41(12): 1271–1275.


• 4. Victorri-Vigneau C, Wainstein L, Guillet M, Gérardin M, Jolliet P (2012) Diagnostic de pharmacodépendance : comparaison des points de vue du patient et du médecin. Thérapie , 67(2): 167-172.


• 5. Dailly E, Verdier M, Deslandes G, Bouquié R, Tribut O, Bentué-Ferrer D (2012) Level of evidence for Therapeutic Drug Monitoring of ceftriaxone. Thérapie, 67(2): 145-149.


• 6. Victorri-Vigneau C, Grall-Bronnec M, Guillou-Landreat M, Gérardin M, Wainstein L, Grosclaude C, Jolliet P (2012) Prise en charge de la douleur aiguë chez les patients sous traitements de substitution aux opiacés. Douleur et analgésie , 25: 83-86.


• 7. Wainstein L, Victorri-Vigneau C, Jolliet P (2012) Nouvelle approche pharmaco-épidémiologique dans le champ de l’Addictovigilance. La Lettre du Pharmacologue , 26(1): 24-29.


• 8. Canevet J, Godard M, Le Mauff P, Bonnaud-Antignac A (2012) L’observation participante comme outil de formation à la relation médecin-patient. Exercer, 101: 79-83.


• 9. Canevet J, Bonnaud-Antignac A, Mollet V, Le Mauff P (2012) Consommateurs de benzodiazépines au long cours : qu’en pensent leurs médecins généralistes prescripteurs ?. Exercer : 52-8.


• 10. Rousselet M, Rocher B, Lambert S, Chaillou L, Vénisse JL (2012) La prise en charge des troubles du comportement alimentaire. Médecine des Maladies Métaboliques, 6(2): 137-142.


• 11. Wainstein L, Grall-Bronnec M, Challet G, Lagadec M, Rousselet M, Vénisse JL (2012) Jeu pathologique et maladie de Parkinson : à propos d’un cas clinique. Alcoologie & Addictologie, 34(2): 137-142.


• 12. Caillon J, Grall-Bronnec M, Challet G, Lagadec M, Vénisse JL (2012) Le jeu pathologique a l’adolescence. Arch Pediatr, 28(2): 239-252.


• 13. Thibault R, Jaccard S, Dessomme B, Navas D, Paillé C, Moret L, Darmaun D (2012) Evaluation des pratiques professionnelles en nutrition parentérale chez l’adulte au centre hospitalier universitaire de Nantes. Nutrition Clinique et Métabolisme, 26: .


• 14. Rezvani M, Maître A, Grall-Bronnec M (2012) L'addiction au travail : à propos d'un cas. Alcoologie et Addictologie, 34(2): 113-119.


• 15. Bourdon M (2012) Spiritualité et santé. Face à un diagnostic de cancer. Le journal des psychologues, 303: 23-27.

Thèses/Rapports/Mémoires

• 1. Vanier A (2012) Thèse d'exercice pour le diplôme d'état de Docteur en médecine, DES de Santé Publique - Université de Nantes. L’évaluation de l’efficacité du dépistage systématique du cancer du sein dans la littérature internationale. , 166 pages.


• 2. Hardouin JB (2012) Validation, Planification et Analyse d’échelles de mesure de concepts latents dans le domaine de la santé. Habilitation à Diriger les Recherches, Ecole doctorale Biologie Santé, 117 pages.

2011

Articles dans une revue internationale

• 1. Dantan E, Joly P, Dartigues JF, Jacqmin-Gadda H (2011) Joint model with latent state for longitudinal and multistate data. Biostatistics, 12(4): 723-736.


• 2. Aubert- Wastiaux H, Moret L, Le Rhun M, Fontenoy A, NGuyen JM, Leux C, Misery L, Young P, Chastaing M, Danou N, Lombrail P, Boralevi F, Lacour J, Mazereeuw-Hautier J, Stalder J, Barbarot S (2011) Topical Corticosteroid Phobia in Atopic Dermatitis: A Study of its Nature, Origins and Prevalence. British J Dermatol, 165(4): 808-14.


• 3. Oulhote Y, Le Bot B, Poupon J, Lucas JP, Mandin C, Etchevers A, Zmirou-Navier D, Glorennec P (2011) Identification of sources of lead exposure in French children by lead isotope analysis: a crosssectional study. Environmental Health, 10: 75.


• 4. Grall-Bronnec M, Wainstein L, Augy J, Challet G, Feuillet F, Vénisse JL, Sébille V (2011) Attention deficit hyperactivity disorder among pathological and at-risk gamblers seeking treatments: a hidden disorder. Eur Addict Res, 17(5): 231-240.


• 5. Aboab J, Sébille V, Jourdain M, Mangalaboyi J, Gharbi M, Mansart A, Annane D (2011) Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. Intensive Care Medicine, 37(8): 1344-1351.


• 6. Hardouin JB, Conroy R, Sébille V (2011) Imputation by the mean score should be avoided when validating a Patient Reported Outcomes questionnaire by a Rasch model in presence of informative missing data. BMC Medical Research Methodology, 11(105): 1-13.


• 7. Degauque N, Boeffard F, Foucher Y, Ballet C, Brouard S, Soulillou JP (2011) The Blood of Healthy Individuals Exhibits CD8 T Cells with a Highly Altered TCR Vb Repertoire but with an Unmodified Phenotype. PLoS One, 6(6): e21240.


• 8. Brouard S, Le Bars A, Dufay A, Gosselin M, Foucher Y, Guillet M, Cesbron A, Thervet E, Legendre C, Dugast E, Pallier A, Guillot-Gueguen C, Lagoutte L, Evanno G, Giral M, Soulillou JP (2011) Identification of a gene expression profile associated with operational tolerance among a selected group of stable kidney transplant patients. Transplantation International, 24(6): 536-547.


• 9. Pipet A, Allain-Veyrac G, Wessel F, Jolliet P, Magnan A, Demoly P, Bousquet PJ (2011) A statement on cefazolin immediate hypersensitivity: data from a large database, and focus on the cross-reactivities. Clin Exp Allergy, 41: 1602-1608.


• 10. Racapé M, Duong Van Huyen J, Danger R, Giral M, Bleicher F, Foucher Y, Pallier A, Pilet P, Tafelmeyer P, Ashton-Chess J, Dugast E, Pettre S, Charreau B, Soulillou JP, Brouard S (2011) The involvement of SMILE/TMTC3 in endoplasmic reticulum stress response. PLoS One, 6(5): e19321.


• 11. Roquilly A, Mahé PJ, Seguin P, Floch H, Tellier AC, Merson L, Renard B, Mallédant Y, Flet L, Sébille V, Volteau C, Masson D, NGuyen JM, Lejus C, Asehnoune K (2011) Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study. JAMA: 1201-1209.


• 12. Dailly E, Bouquié R, Deslandes G, Jolliet P, Le Floch R (2011) A liquid chromatography assay for a quantification of doripenem, ertapenem, imipenem, meropenem concentrations in human plasma: application to a clinical pharmacokinetic study. Analyt Technol Biomed Life, 879(15): 1137-1142.


• 13. Gérardin M, Victorri-Vigneau C, Louvigne C, Rivoal M, Jolliet P (2011) Management of cannabis use during pregnancy: an assessment of healthcare professionals'practices. Pharmacoepidemiol Drug Saf, 20(5): 464-73.


• 14. Blanchin M, Hardouin JB, Le Neel T, Kubis G, Blanchard C, Mirallié E, Sébille V (2011) Comparison of CTT and IRT based-approach for the analysis of longitudinal Patient Reported Outcome . Statistics in Medicine, 30(8): 825-838.


• 15. Lebeau JP, Pouchain D, Huas D, Wilmart F, Dibao-Dina C, Dibao-Dina C, Boutitie F (2011) ESCAPE-ancillary blood pressure measurement study: end-digit preference in blood pressure measurement within a cluster-randomized trial. Blood Press Monit, 16(2): 74-9.


• 16. Wainstein L, Victorri-Vigneau C, Sébille V, Hardouin JB, Feuillet F, Pivette J, Chaslerie A, Jolliet P (2011) Pharmacoepidemiological characterization of psychotropic drugs consumption using a latent class analysis. International Clinical Psychopharmacology, 26(1): 54-62.


• 17. Hardouin JB, Bonnaud-Antignac A, Sébille V (2011) Non parametric Item Response Theory using Stata. The Stata Journal, 11(1): 30-51.


• 18. Blanchin M, Hardouin JB, Le Neel T, Kubis G, Sébille V (2011) Analysis of longitudinal Patient-Reported Outcomes with informative and non-informative dropout: Comparison of CTT and Rasch-based methods. International Journal of Applied Mathematics & Statistics (IJAMAS), 24: SI-11A.


• 19. Pottier P, Hardouin JB, Dejoie T, Le Loupps AG, Bonnaud-Antignac A, Planchon B, Leblanc V (2011) Stress responses in medical students interacting with real ambulatory symptomatic. Medical Education, 45(7): 678-687.


• 20. Guitton C, Gérard N, Sébille V, Villers D, Boutoleau-Bretonnière C, Quillard T, Charreau B (2011) Early rise in circulating endothelial protein C receptor correlates with poor outcome in severe sepsisechanisms in vascular endothelial cells. Intensive Care Medicine, 37(6): 950-956.


• 21. Allain-Veyrac G, Lebreton A, Collonnier C, Jolliet P (2011) First case of symmetric drug-related intertriginous and flexural exanthema (sdrife) due to rivastigmine?. Am J Clin Dermatol, 12(3): 210-213.


• 22. Tripodi D, Ferron C, Malard O, De Montreuil C, Planche L, Sébille V, Roedlich C, Quéméner S, Renaudin K, Longuenesse C, Verger C, Meflash K, Gratas C, Géraut C (2011) Relevance of both individual risk factors and occupational exposure in cancer survival studies: the example of intestinal type sinonasal adenocarcinoma. Laryngoscope, 121(9): 2011-2018.


• 23. Asehnoune K, Roquilly A, Sébille V (2011) Corti-TC trial group. Corticotherapy for traumatic brain-injured patients--the Corti-TC trial: study protocol for a randomized controlled trial. Trials, 12: 228.


• 24. Victorri-Vigneau C, Sébille V, Gérardin M, Simon D, Pivette J, Jolliet P (2011) Epidemiological characterization of drug overconsumption: the example of antidepressants. Journal of Addictive Disease, 30(4): 342-350.


• 25. Roquilly A, Mahé J, Latte D, Loutrel O, Champin P, Di Falco C, Courbe A, Buffenoir K, Hamel O, Lejus C, Sébille V, Asehnoune K (2011) Continuous controlled-infusion of hypertonic saline solution in traumatic brain-injured patients: a 9-year retrospective study. Critical Care , 15(5): R260.


• 26. Lelorain S, Tessier P, Florin A, Bonnaud-Antignac A (2011) Predicting Mental Quality of Life in Breast Cancer Survivors Using Comparison Participants. Journal of Psychosocial Oncology, 29(4): 430-449.


• 27. Lelorain S, Tessier P, Florin A, Bonnaud-Antignac A (2011) Posttraumatic growth in long term breast cancer survivors: relation to coping, social support and cognitive processing. Journal of Health Psychology, 17(5): 627-639.


• 28. Collette M, Humeau A, Chevalier C, Hamel JF, Leftheriotis G (2011) Assessment of aortic stiffness by local and regional methods . Hypertens: online.


• 29. Bretaudeau M, Hamel JF, Bretaudeau M, Harry P (2011) European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments. Clinical toxicology, 50(3): 646-647.


• 30. Bouquié R, Deslandes G, Renaud C, Dailly E, Haloun A, Jolliet P (2011) Colchicine-induced rhabdomyolysis in a heart/lung transplant patient with concurrent use of ciclosporine, pravastatin and azithromycin. Journal of Clinical Rheumatology: .